WO1998028444A2 - Customized oligonucleotide microchips as multiple biosensors - Google Patents

Customized oligonucleotide microchips as multiple biosensors Download PDF

Info

Publication number
WO1998028444A2
WO1998028444A2 PCT/US1997/023778 US9723778W WO9828444A2 WO 1998028444 A2 WO1998028444 A2 WO 1998028444A2 US 9723778 W US9723778 W US 9723778W WO 9828444 A2 WO9828444 A2 WO 9828444A2
Authority
WO
WIPO (PCT)
Prior art keywords
microchip
seq
oligonucleotides
hybridization
rna
Prior art date
Application number
PCT/US1997/023778
Other languages
French (fr)
Other versions
WO1998028444A3 (en
Inventor
Andrei Mirzabekov
Dmitry Y. Guschin
Valentine Shik
Alexander Fotin
Gennadiy Yershov
Yu Lysov
Original Assignee
The University Of Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Chicago filed Critical The University Of Chicago
Priority to EP97953408A priority Critical patent/EP0951569A2/en
Priority to AU57160/98A priority patent/AU5716098A/en
Publication of WO1998028444A2 publication Critical patent/WO1998028444A2/en
Publication of WO1998028444A3 publication Critical patent/WO1998028444A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Definitions

  • This invention relates to using customized oligonucleotide microchips as biosensors for the detection and identification of nucleic acids specific for different genes, organisms and/or individuals in the environment, in food and in biological samples.
  • Environment includes water, air and soil.
  • Biological samples include blood, skin, tumors amniotic fluid, tissues, cells and cell cultures. Detection of sequences in nucleic acids is used to identify microorganisms in a sample, to diagnose genetic defects or polymorphisms, to detect gene expression and for forensic studies.
  • DNA probes are now commonly used to detect by hybridization, genes encoding proteins involved in specific catabolic functions, and to resolve different genetic populations in the environment.
  • group-specific DNA probes complementary to the small subunit (SSU) 16S rRNA has provided a comprehensive framework for studies of microbial population structure in complex systems. Sequencing of this subunit revolutionized microbial classification and led to the discovery of archebacteria . (Woese, 1987) A large number of the sequences for different organisms has been collected. (Maidak et al . , 1996) Every microorganism species is characterized by a specific
  • DNA sequence within a variable region of its ribosomal RNA gene or other genes is based on these observations. Identification of specific sequences in ribosomal DNA is a reliable microbial analysis that can be carried out by direct DNA sequencing.
  • DNA sequencing is a rather complicated, expensive and time consuming procedure to use for serial microbial analysis on a commercial scale for environmental or medical applications. Consequently, new methods are needed to make sequence matching commercially feasible.
  • a nucleic acid hybridization is a highly specific and sensitive procedure that allows a specific sequence to be detected and identified among other millions of sequences in a genome of higher organisms, or among a mixture of different organisms .
  • the principle of hybridization is that sequences hybridize as a function of the similarity of their linear nucleotide sequence.
  • the hybridization of DNA or RNA extracted from even a very complicated mixture to a specific oligonucleocide probe has resulted in unambiguous identification of specific microorganisms in an environmental sample, for example.
  • RNA or DNA is extracted from a sample of microorganisms isolated from water solutions, air or soil, immobilized on a filter and then hybridized successively with several oligonucleotide probes for different microorganisms.
  • the sample needs to be checked for the presence of hundreds or thousands of different oligonucleotides corresponding to various microorganisms which is prohibitively laborious and expensive using present methods.
  • nucleotide hybridization is often limited by the nature of the assays, generally involving the independent hybridization of multiple environmental samples to multiple DNA probes.
  • some detection assays require amplification of the target nucleic acid, for example, via PCR. This may contribute to quantitative biases.
  • assays that provide for greater sample through-put capacity and greater sensitivity.
  • DNA or RNA sequences are of interest.
  • the number of base changes discovered (mutations) in different genes is growing rapidly. These changes are associated with genetic diseases, with disease predispositions and cancers, with develop- ment of drug resistance in microorganisms, and with genetic polymorphisms .
  • Polymorphisms are useful for determining the source of a sample, e.g. in forensic analyses. Polymorphisms such as in the HLA system are essential to predict success of tissue transplants.
  • the ability to simultaneously analyze many mutations in a gene in a simple, fast, and inexpensive way is essential in clinical medicine and this need has stimulated the development of different methods for screening mutations, but all have serious limitations .
  • Hybridization of filter- immobilized DNA with allele-specific oligonucleotides was suggested as a way to screen for mutations. (Conner et al . , 1983) However, the number of alleles that can be assayed at one time is limited, the filters are usable only for a few times, and there is little opportunity for complex analysis .
  • a possible solution to large scale hybridization is to use microchips for DNA sequence hybridizations (SHOM, sequencing by hybridization with oligonucleotides in a microchip) (e.g. Khrapko, 1996; Yershov, 1996) .
  • oligonucleotide chips permit simultaneous analysis of many mutations (for a review, see Mirzabekov, 1994) .
  • Such arrays can be manufactured by a parallel synthesis of oligonucleotides (Southern et al . , 1992; Fodor et al . , 1991; Pease et al . , 1994;
  • Glass surfaces Southern et al . , 1992; Fodor et al . , 1991; Ghu et al . , 1994), glass pores (Beattie et al . , 195), polypropylene sheets (Matson et al . , 1995), and gel pads (Khrapko et al . , 1991; Yershov et al . , 1996) have been used as solid supports for oligonucleotide immobilization.
  • "Oligonucleotide array technology has not yet lived up to its promise.”
  • This invention embodies applications of oligonucleotide microchip technology wherein the microchip is a biosensor and customized oligonucleotide microchips are designed for specific applications of nucleic acid hybridization.
  • Hybridization is a process by which, under defined reaction conditions, partially or completely complementary nucleic acids are allowed to join in an antiparallel fashion to form specific and stable hydrogen bonds .
  • aspects of the invention include improved predictability, increased accuracy, and standardized factors for detection and identification of nucleotide sequences.
  • the improvements result from optimizing conditions, methods and compositions for microchip hybridization. Ordered schemes are followed so that much information can be obtained from a single scan of a microchip to detect hybridization of oligonucleotides in a sample to be investigated.
  • Samples include air, water, soil, blood, cells, tissue, tissue culture and a food.
  • An aspect of the invention is that the same microchip can be used for hybridization for more than 20-30 times, without any noticeable deterioration of the hybridization signal. Customized sets of microchips are obtained for specific applications.
  • sequence diversity of SSU rRNAs recovered from different microbial populations of varying abundances is analyzed by a single hybridization to a microchip. A large number of HLA alleles, are assayed by a single hybridization to a microchip.
  • the invention relates a method for identifying a nucleotide sequence in a sample using a microchip, said method comprising: a) extracting nucleic acids from said sample ; b) providing a customized matrix of oligonucleotides on the microchip designed to identify the sequence in the sample; c) hybridizing said extracted nucleic acids as such or after amplification on said microchip; and d) identifying the nucleotide sequence represented in said sample by comparing the identity of the oligonucleotides which hybridized to the sequence and the oligonucleotides not hybridized.
  • the nucleic acids include DNA, mRNA, 16S rRNA sequences and other RNA species.
  • Customized oligonucleotide microchips are aspects of the invention.
  • the microchip includes a gel -matrix affixed to a support, said matrix is formed by a plurality of gel pad element sites. The number of sites is determined by the number of oligonucleotides in the array.
  • Each gel element contains one chemically immobilized oligonucleotide of a desired sequence, length and concentration; the gel elements being separated from one another by hydrophobic glass spaces and the gel portions having a vertical height above the plane of the interstitial spaces of generally not more than 30 ⁇ m.
  • the invention relates screening nucleic acid preparations for genes, RNA transcripts or any other unique nucleotide sequences, for example those that encode microbial 16S ribosomal RNAs . Ratios of DNA/RNA or any other unique nucleotide sequences specific for certain types of organisms are suitable. Multiple labeling allows simultaneous detection and quantitative comparison of different nucleic acid sequences that are hybridized to a microchip.
  • the methods of the present invention include labeling the oligonucleotide sequence in said sample before bringing it in contact with the array.
  • a suitable label is a fluorescent dye.
  • a plurality of different dyes may be used concurrently.
  • Oligonucleotides on a customized microchip include those complementary to the beta globin gene, sequences specific for Salmonella , or polymorphic HLA allele sequences.
  • An oligonucleotide microchip for the detection and classification of nitrifying bacteria has a customized design wherein identifying labels in the cells of the microchip refer to oligonucleotides selected from a class of bacteria, and the selection is designed to answer specific questions regarding classification.
  • An embodiment of an application of the present invention is detecting and identifying microorganisms in samples obtained from the environment, e.g. water, air or soil samples to check for pollutants; biological samples obtained for medical diagnosis; or food samples to check for contamination.
  • Other applications include forensic testing to identify DNA in samples obtained for criminal investigations, and detection of chromosomal fragments, or single gene mutations e.g. for diagnosing genetic diseases such as ⁇ -thalassemia or types of cancers. Tissue typing for polymorphic HLA alleles for transplantation or studying human diversity is facilitated.
  • the nucleic acid preparations are made from samples collected in any type of environment, where detection and identification of the microorganisms in that environment is of interest, or where it is likely that new (previously unidentified) organisms may be discovered.
  • the volume of each microchip is great enough to accommodate a high surface concentration of probes, allowing a large dynamic range for measurement.
  • DNA and RNA molecules in a sample can be separated from each other during their isolation and labeled with different fluorescent dyes. These RNA and DNA molecules are simultaneously hybridized with oligonucleotides on a microchip that is specific to the sample to be tested.
  • the quantitative monitoring of the simultaneous hybridization of differently labeled DNA and RNA with a microscope that can discriminate multicolors at several wave lengths allows the calculation of DNA/RNA ratios in the sample. For bacterial samples, this ratio determines the state of vitality and physiological activity of the bacterium.
  • the ratio of RNA/DNA is used to discriminate the dead bacterium cells and spores from the active state of microbial growth.
  • a DNA or RNA molecule of a bacterial strain stained with one dye can be added in a calculated amount as an internal standard to a sequence or sequences under investigation in which the sequences being investigated stained with a different (second) dye.
  • the fluorescence measurements of hybridization intensities at different wave lengths for the standard and investigated sequences (probes) allow relative quantitative ratios to be determined.
  • Microchip hybridization is a simple, fast, inexpensive and reliable method for bacterial typing.
  • An aspect of the invention is that there is no limitation on the number of sequences that can be checked or the number of types of microorganisms that can be detected. Instead of multiple sequential hybridizations with different probes of, e . g. a 16S rRNA preparation, only one round of hybridization is required to find out what different sequences are in a sample. The volume of hybridizations is dramatically reduced and the assay requires much less RNA or DNA compared with standard techniques . An advantage is that culturing of bacteria and gene amplification can be avoided.
  • Methods of the invention significantly reduce sample preparation time, avoid the culturing of organisms collected from field situations, and allow the identification of all species of microorganisms contained in a particular sample.
  • oligonucleotides complementary to small subunit rRNA sequences of selected microbial groups were shown to selectively retain labeled target nucleic acid derived from either DNA or RNA forms of the target sequences.
  • Methods and compositions of the present invention discriminate among the Genera, Ni trosomonas , Ni trobacter and Ni trosovibrio sp . using fluorescently labeled nucleic acid probes that hybridize to 16S rRNA sequences.
  • Each species has specific DNA sequences within the variable region of its rRNA genes. Since the rRNAs are naturally amplified, often present in thousand of copies per cell, they provide greater sensitivity, eliminating the need for amplification in many applications.
  • the invention facilitates identification of organisms from environmental samples in a faster, and more economical approach than presently available.
  • new species may be discovered that would be highly informative regarding taxonomic status of known as well as newly discovered organisms.
  • a diagnostic assay of the present invention for a mutation in a gene includes the following steps: a. designing a customized oligonucleotide microchip biosensor comprising oligonucleotides that hybridize to a gene having the mutation; b. contacting a nucleic acid sample to the customized oligonucleotide microchip biosensor under conditions that allow hybridization of the nucleic acid to the microchip; and c. determining whether hybridization occurs from which observation the presence of the specific nucleic acid sequence is inferred.
  • sequence analysis of DNA is carried out by hybridization of PCR amplified DNA or its RNA transcripts with oligonucleotide array microchips.
  • Polyacrylamide gel pads containing allele-specific immobilized oligonucleotides are fixed on a glass slide of the microchip.
  • the RNA transcripts of PCR-amplified genomic DNA are fluorescently labeled by enzymatic or chemical methods and hybridized with the microchip.
  • the simultaneous measurement in real time of the hybridization and melting curves on the entire oligonucleotide array is carried out with a fluorescence microscope equipped with CCD camera.
  • the monitoring of the hybridization specificity for duplexes with different stabilities and AT content is enhanced by its measurement at optimal discrimination temperatures on melting curves.
  • Microchip diagnostics are optimized by choosing the proper allele-specific oligonucleotides from among the set of overlapping oligomers.
  • the accuracy of mutation detection can be increased by simultaneous hybridization of the microchip with at least two differently labeled samples of normal and mutated alleles, and by parallel monitoring their hybridization with a multi-wavelength fluorescence microscope. The efficiency and reliability of the sequence analysis was demonstrated by diagnosing ⁇ -thalassemia mutations and HLA polymorphisms .
  • Determining levels of gene expression is an aspect of the invention. Because the methods of the present invention require only a simple procedure of hybridization and because only one round of hybridization is necessary, it is fast and inexpensive. Because the invention allows a lot of information to be obtained from one experiment, it is efficient. The invention is reliable because the microchips are reusable. There is no waste of hybridization probes, therefore the microchip hybridization is inexpensive and non-isotopic detection simplifies all procedures. Effective and precise sequence analysis by the hybridization of a probe with rather short microchip- immobilized oligonucleotides depends on many factors.
  • Major factors are the reliability of the discrimination of perfect duplexes from duplexes containing mismatches, differences in stability of AT- and GC-rich duplexes, the efficiency of the hybridization, and simplicity in the preparation of the labeled samples for hybridization.
  • Identification of base variations is significantly improved by parallel measuring of the melting curves of the duplexes formed on the entire oligonucleotide array, as well as by monitoring the simultaneous hybridization of two differently labeled samples at two wavelengths and by choosing proper allele-specific oligonucleotides.
  • Other factors to be considered for operation of the invention include (1) regulating the flow of the fluid containing a sample to be tested over the microchip during the hybridization; and (2) control of the temperature of the microchip gel layer and the fluid layer, in a differential manner, by placing a cooling and heating apparatus adjacent to the gel layer and the top fluid layer.
  • the gel layer temperature is controlled in a uniform or gradient manner by a heating/cooling device attached to the glass plate substrate of the gels.
  • FIG. 1 shows non-equilibrium melting curves of duplexes of RNA with microchip oligonucleotides.
  • FIG. 2 shows an example of four melting curves for 75 -nt- long RNA fragments hybridized with the microchip oligonucleotides.
  • the RNA was derived from a patient having the IVS 1/2 T/A mutation in the ⁇ -globin gene. The curves were normalized to the initial hybridization signals. Melting curves 1 and 3 correspond to perfect duplexes; curves 2 and 4 correspond to duplexes containing internal T-T or G-T mismatches, respectively. The curves for the perfect and mismatched duplexes are shifted by about 10 °C from each other.
  • FIG. 3 shows hybridization of fluorescein labelled 16S rRNAs to a microchip.
  • the microchip with immobilized probes (see Table 1 and Table 2) was hybridized sequentially to in vi tro transcribed 16S rRNA of Ni trosovibrio tenuis (A), Ni trosomonas europaea
  • FIGS. 4A and 4B show hybridization of the mixture of differently labelled E. coli and
  • Ni trosovibrio tenuis rRNAs to the microchip at 10 °C and
  • B. The ratio of the hybridization intensities of Ni trosovibrio tenuis (I Nt ) to E. coli (I E . coll ) 16S RNA measured at 10°C and 40°C. R (INt/ IE coll ) .
  • FIG. 5 illustrates the concentration effect of the immobilized oligonucleotides on the hybridization intensities.
  • a microchip with different concentrations of immobilized oligonucleotides was hybridized with N. tenuis 16S rRNA labelled with fluorescein and washed at 20°C.
  • Curve 1 corresponded to Nsv443 (nitrosovibrio-like) probe
  • curve 2 Bac338 (Bacteria)
  • curve 3 - Nsol225 ammonia oxidizers
  • curve 4 - Unil390 all life
  • FIG. 6 shows the sequences of ⁇ -globin alleles specifying oligonucleotides that were immobilized on a microchip.
  • FIG. 7 shows the experimental design to detect ⁇ -globin mutations using oligonucleotide microchips .
  • FIG. 8 shows results of gene expression studies.
  • FIG. 9 shows 18 short HLA oligonucleotides.
  • FIG. 10 shows HLA oligonucleotides hybridized to the microchips .
  • This invention relates to using customized oligonucleotide microchips as biosensors for the detection and identification of nucleic acids specific for different genes, organisms and individuals in the environment, in food and in biological samples.
  • “Environment” includes water, air and soil.
  • Biological samples include blood, skin, tumors amniotic fluid, tissues, cells and cell cultures. Detection of sequences in nucleic acids is used to identify microorganisms in a sample, to diagnose genetic defects or polymorphisms, to detect gene expression and for forensic studies.
  • a nucleic acid hybridization is a highly specific and sensitive procedure and allows a specific sequence to be detected and identified among other millions of sequences in a genome of an organism.
  • nucleic acid hybridization is a useful but quite a cumbersome procedure .
  • This drawback can be overcome by using oligonucleotide microchips as biosensors for different microorganisms. Within a small area of a few square millimeters or centimeters, hundreds and thousands of synthetic oligonucleotide probes are immobilized that are specific to ribosomal DNA or to other specific nucleic acids. Subsequent hybridization of a DNA or RNA molecule to the microchip enables a menu of oligonucleotides to be identified in a sample. For bacterial assays, pure culture microorganisms, purified target nucleic acid or even synthetic oligonucleotides are useful as internal standards, serving to estimate the efficiency of nucleic acid isolation or the absolute amount of target nucleic acid
  • the customized oligonucleotide microchips are produced by chemical immobilization of presynthesized oligonucleotides, or by direct synthesis of oligonucleotides on a microchip. If a microchip contains rather long oligonucleotides, the former methods are the methods of choice because before immobilization, the oligonucleotides are purified and checked for their quality.
  • the oligonucleotide microchips consist of many polyacrylamide gel pad elements generally of the size of 40x40x20 ⁇ m and larger. The elements are chemically fixed on a glass surface. Each microchip gel element contains a specific presynthesized oligonucleotide that is immobilized through a covalent bond. Hundreds of microchips containing hundreds and thousands of different immobilized oligonucleotides can be manufactured by a specially devised robot .
  • the gel array also offers several advantages over formats using an in si tu synthesis of the oligonucleotide array.
  • the synthetic oligonucleotides are purified by gel electrophoresis or HPLC prior to immobilization on the microchip.
  • the polyacrylamide gel support has a capacity of immobilized oligonucleotides from 0.03 pmol up to 10 pmol per 100x100x20 ⁇ m gel pad. This offers improved quantification and better discrimination between perfect and mismatched duplexes. It also provides a way to normalize differences in hybridization signal intensities .
  • Oligonucleotide microchip technology for sequencing by hybridization is available to identify the presence of microorganisms in a sample of any type, or to find new species .
  • the hybridization of DNA or RNA extracted from even a very complicated mixture to a specific oligonucleotide probe has resulted in unambiguous identification of microorganisms.
  • the nucleotide sequence of the microorganisms for genes encoding a small subunit of ribosomal 16S rRNA forms the basis for a microchip biosensor.
  • hybridization analysis of DNA or RNA samples with oligonucleotides specific for the microorganisms is performed. This new technology provides efficient microbial analysis and environmental monitoring.
  • Microorganism biosensor technology is developed, customized microbial oligonucleotide microchips are produced by methods of the present invention, and methods are developed for simultaneous quantitative and qualitative microchip analysis of hundreds and thousands of microorganisms in a sample and for discovery of new ones .
  • Other applications include detection of genetic mutations such as are characteristic of hemo- globin disorders; detection of genetic polymorphisms such as HLA; investigation of gene expression; detection of causative agents of diseases; forensic studies; and detection of microbial pollutants.
  • Oligonucleotides are synthesized using a 394 DNA/RNA synthesizer (Applied Biosystems) . The synthesis of oligonucleotides for immobilization began with 3 -methyluridine at the 3 ' -terminal position. In one embodiment, fluorescently labeled RNA was prepared using T7 RNA polymerase. Template DNA (133 and 75 bp long) for in vi tro transcription was prepared by PCR amplification with the nested primers T7V2L-45, 5'-
  • a polyacrylamide gel micromatrix was prepared by photopolymerization of a solution of 4% acrylamide (acrylamide/bisacrylamide 19/1), 40% glycerol , 0.0002% methylene blue, and 0.012% TEMED in 0.1 M sodium- phosphate buffer, pH 7.0. The mixture was applied to an assembled polymerization chamber illuminated with U.V. light.
  • micro- matrices Two types of microchip matrices (micro- matrices) were routinely prepared with gel pad elements of about 60x60x20 ⁇ m and 100x100x20 ⁇ m that were spaced by 120 and 220 ⁇ m, respectively. About 1 nl of activated oligonucleotide solution was transferred to a gel element using either a robot or a simple manual device.
  • the device includes a Peltier thermostated pin placed under a binocular lens in conjunction with a micromanipulated holder, a power supply, an a refrigerated circulator.
  • the manufacture of microchips of gel- immobilized oligonucleotides basically consists of three steps; shaping the desired topology of oligonucleotides on a gel micromatrix; loading microvolumes of oligonucleotide solutions onto the micromatrix, and immobilizing within the gel oligonucleotides containing the active 3' or 5' terminal aldehyde or amine groups. To avoid the exchange of different oligonucleotide solutions applied on adjacent gel pads, the pads are separated on the micromatrix by a hydrophobic glass surface.
  • Two-dimensional scribing or laser evaporation is used for micromatrix preparation, but these procedures require rather complex equipment and experienced personnel.
  • the photopolymerization method significantly simplifies the procedure and makes it accessible to a biochemical laboratory.
  • Microfabrication by mask-directed photopolymerization e.g., a photoresist method in microelectronics
  • a photoresist method in microelectronics is a well developed technique. From several acrylamide photopolymerization techniques tested, modified - methylene - blue induced photo- polymerization produced the best results for micromatrix manufacture.
  • the gel matrix consists of gel pads photopolymerized on a glass slide. The gel pads are formed according to the mask topology due to the lack of photopolymerization in places covered by a nontransparent grid.
  • the microchip is manufactured by applying the activated oligonucleotide solutions onto the micro- matrix of gel elements containing active hydrazide or aldehyde groups .
  • the transfer is carried out by the hydrophilic upper surface of a pin that is first immersed into, and is wetted with, an oligonucleotide solution, and then is withdrawn from the solution and brought into contact with the gel surface. This transfers about 1 nl of oligonucleotide solution with a reproducibility of ⁇ 10%.
  • the temperature of the pin is maintained near the dew point of the ambient air to avoid the evaporation of this microvolume solution in the course of transfer.
  • Example 2 The hybridization of microchips with DNA and RNA
  • Fluorescently labeled DNA or RNA (5 ⁇ l , 0.1-1 pmol/ ⁇ l were hybridized to a microchip at -t-5°C in a hybridization buffer containing 1 M NaCl, 1 mM EDTA, 1% Tween-20, and 10 mM sodium phosphate at a pH of 7.0, for between about 2-24 h.
  • the microchip was covered with a cover glass or a Teflon sheet so that a 300-um space is above. Then the hybridization solution containing DNA or RNA fragments was substituted with 10 ⁇ l of cooled hybridization buffer.
  • the microchip with the cover glass was placed on a thermostabilized table. Hybridization was monitored quantitatively using a specially constructed multicolor epifluorescent microscope with a 4x4 mm observation field equipped with a CCD camera and suitable software.
  • the polyacrylamide gel used on a microchip provides more than 100 times higher capacity for three- dimensional immobilization of oligonucleotides than does a two-dimensional glass surface.
  • the high concentration of immobilized oligonucleotides facilitates the discrimination of mismatched duplexes and enhances the sensitivity of measurements on the microchips. This allows the use of a CCD-camera- equipped fluorescence microscope (Yershov et al . , 1996) although it is less sensitive than laser scanning systems (Lipshutz et al . , 1995), but offers the advantage of monitoring the hybridization on a microchip at different temperatures in real time for measurement of the melting curves.
  • Melting curves are defined herein as produced by plotting the amount of duplexes [fluorescent intensity] versus temperature.
  • the procedure, the software, and the hybridization microchamber (Yershov et al . , 1996) have all been developed for recording melting curves at a wide range of temperatures simultaneously for perfect and mismatched duplexes formed upon hybridization of a probe with all microchip oligonucleotides.
  • This invention embodies an improvement in the SHOM technology in which hybridizations between an array of gel-immobilized nucleotides (a microchip) and the unknown nucleotides to be tested are measured at optimal, discriminatory melting temperatures.
  • This improvement is achieved by parallel measuring of the melting curves of the duplexes formed by hybridization on the entire oligonucleotide array, as well as by monitoring the simultaneous hybridization of two samples of nucleotides labeled with different fluorochromes, and judicious choice of proper allele- specific oligonucleotides as the immobilized probes.
  • the fluorochromes chosen for the labeling emit light of sufficiently differing wavelengths, that both types of labels can be measured in the same reaction mixture.
  • Td. The temperature at which the initial signal of hybridization drops by a factor of 10 is termed the discrimination temperature (Td.).
  • RNA transcripts of PCR-amplified DNA were hybridized with immobilized oligonucleotides; (2) the Td values for perfect 40% and 70% GC-rich duplexes were 52° and 64°, respectively; (curves 1 and 3 in FIGS. 1A and IB); (3) the immobilized oligonucleotides were chosen from among a set of overlapping sequences; and (4) the two samples included in the reaction mixture were a mutated allele RNA labeled with one fluorochrome and a sample of the normal allele RNA labeled with a different fluorochrome .
  • the Td is determined by hybridization with an RNA sample if an allelic DNA is available. If such DNA is unavailable, the Td can be measured from the hybridization data resulting from experiments performed with synthetic oligonucleotides corresponding to the mutated allele of interest.
  • the dissociation curves for perfect and mismatched duplexes are parallel at the range of about 10° (in the middle of the curves) when plotted on a semilogarithmic scale. At this 10°C range, the ratios of the signals for perfect and mismatched duplexes remain rather constant. This makes the discrimination procedure robust to some inaccuracies in determining Td.
  • the discrimination temperature depends on experimental conditions (rate of heating, ionic strength, probe concentration, extent of fragmentation, and so forth) which can vary from one experiment to another. However, these variations affect Td and the relative intensities of the hybridization signals to a similar extend for all microchip elements and therefore do not significantly distort the discriminations. Therefore, to provide a reference Td, the oligonucleotides CD26 (N) and CD 26 G/A, which form perfect and mismatched duplexes, respectively, with all RNAs tested, were introduced into the microchip.
  • a mixture of fluorescently labeled RNA samples was prepared from two patients; the first sample was TMP- labeled RNA from a patient that is homozygous for the normal CD26 area of the beta-globin allele; the second sample is fluorescein-labeled RNA from a patient that is heterozygous for the normal CD26 area and a mutation CD26 G/A alleles.
  • This mixture was hybridized with a microchip consisting of two microchip elements that contained the following immobilized oligonucleotides :
  • the underlined bases indicate the position of a nucleotide change between the two samples.
  • FIG. 2 demonstrates the interaction of sample 1 with the A microchip element; Graph 2 demonstrates the interaction of sample 2 with the A microchip element; Graph 3 demonstrates the interaction of sample 2 with the B microchip element; and Graph 4 demonstrates the interaction of sample 1 interaction with the B microchip element.
  • Example 5 Use of a Customized Microchip
  • Microorganisms that degrade nitroaromatic compounds include Pseudonomas, Arthrobacter, Nocarida, Myco-bacterium, and fungi.
  • Nitrifying bacteria have proved particularly difficult to study using cultivation techniques, such as most probable number (MPN) and selective plating because of their long generation times and poor counting efficiencies. .Thus, a rapid and non-culture dependent enumeration technique for nitrifiers could greatly facilitate research in their ecology.
  • Microchips with 100x100x20 ⁇ m gel pads (alternatively 60x60x20 ⁇ m) , fixed on a glass surface and containing a set of 10 oligonucleotides 15-20 bases-long were manufactured for bacterial typing experiments.
  • the set included oligonucleotides complementary to different regions of 16S ribosomal RNA. Since rRNA's are naturally amplified, and often are present in thousands of copies per cell, they provide great sensitivity and eliminate the need for amplification in many applications.
  • One oligonucleotide is represented in most living organisms, another is typical for most of bacteria and the rest belong to nitrosos (nitrifying) bacteria only.
  • the group of nitrosos bacteria oligonucleotides consists of two oligonucleotides typical of nitrobacter, two typical of nitrosomonas and one typical of nitrosovibrio.
  • One oligonucleotide was complementary to an antisense strand of rDNA for hybridization with ribosomal dsDNA, that was PCR amplified from genomic or cDNA.
  • the following scheme for an ordered oligonucleotide loading is useful for bacterial (or organism, species) typing.
  • the first oligonucleotides characterize the highest order (i.e. to distinguish a living organism) . [Uni 1390-CIII] . Reducing the order step by step down to the lowest level, i.e. from family, to genus, to species provides further discrimination of oligonucleotides that are present in a sample being investigated. For example, for oligonucleotides used to classify nitrifying bacteria, a bacterial oligonucleotide would be in the next position.
  • the microchip was evaluated using three different rRNA preparations (phenol extracts of cellular RNA, RNA isolated from purified ribosomes, and in vi tro transcripts of cloned ribosomal DNA), and both fragmented double-stranded and single-stranded DNA. Hybridizations were performed in a formamide buffer at low temperature in order to enhance microchip durability and decrease RNA degradation. Although all DNA and RNA preparations could be used, the best discrimination was observed for in vi tro transcribed rRNAs using the hybridization conditions evaluated in this study.
  • RNA transcribed in vi tro as well as single- and double-stranded PCR-amplified 16S rDNA were obtained from plasmids containing the cloned 16S rRNA gene. All of these sample types provided a comparatively reliable identification of the microorganisms by their hybridization with the microchip- immobilized oligonucleotides and could be used for different purposes.
  • the rRNA provides a naturally amplified target.
  • RNA and DNA components of an environmental sample could be isolated and labelled with different fluorescent dyes.
  • the resulting ratio of RNA and DNA hybridizing to an individual gel element could be used to infer the physiological status of the corresponding microbial population.
  • Table 2 shows the sequences of the oligonucleotides and other characteristics of them.
  • Hybridization in formamide containing buffer at low temperature gave good results.
  • Hybridizations were performed at 5° centigrade in 33% formamide. RNA samples and covalent bonding of oligonucleotides with the support (hence durability of microchips) are more stable at low temperatures. In addition, these conditions were favorable from a point of view of RNA stability and microchip durability similar to other RNA molecules at low temperatures of about 0°-5°C.
  • the hybridization on a microbial microchip was carried out with in vi tro RNA transcripts of 16S rDNA of different nitroso bacteria, total RNA extracts and ribosomal RNA extracted form E. coli and Desulfovibria vulgurus as well as PCR amplified double or single stranded DNA of 16S rDNA.
  • FIG. 3 shows the fluorescence of individual gel elements on the microchip following hybridization to the 16S rRNAs of Ni trosovibrio tenuis (A), Ni trosomonas europaea (B) , and E. coli , either in vi tro transcribed (C) or recovered from isolated ribosomes (D) .
  • the same microchip was used for each hybridization following washing with distilled water.
  • Each microchip was routinely used for up to 20-30 hybridization experiments.
  • the appropriate pattern of hybridization was observed for all gel elements shown, despite a significant difference in dissociation temperatures (T ds ) previously determined using membrane support hybridization (Table 1) .
  • T ds dissociation temperatures
  • FIGURE 4A and 4B shows the results of an experiment evaluating the effect of increasing washing temperature on target RNA retention.
  • a mixture of Ni trosovibrio tenuis and E. coli 16S rRNA labelled with different fluorescent dyes (fluorescein and tetramethylrhodamine, respectively) was hybridized to the chip at 5°C.
  • the hybridization solution was then replaced with washing buffer and the retention of each RNA species was measured following each 10°C incremental increase in temperature (up to 60°C) using multicolor detection.
  • Nonspecific hybridization of E. coli rRNA to Nsol225 (ammonia oxidizer) , Nsml56 (nitrosomonas) , and NonBac338 (anti-sense) was observed following the 10°C wash.
  • 4B shows the ratios of hybridization intensities of fluorescein labelled Ni trosovibrio tenuis to tetramethylrhodamine labelled E. coli . with different microchip oligonucleotides at 10°C and 40°C (the ratios are derived from the data presented on Figure 4A. These ratios were not changed significantly for oligonucleotides specific to bacteria and all living organisms between 10°C and for more stringent conditions at 40°C. However, the ratio is dramatically increased at 40°C (compared to 10°C) for oligonucleotides specific to ammonia oxidizers and nitrosovibrio.
  • Variable hybridization to the different gel elements is the expected consequence of using a single hybridization condition to evaluate an array of probes, each having different kinetics of association and dissociation. To some extent these difference can be normalized by varying the concentration of oligonucleotides in the individual gel elements. For example, the relatively low hybridization signals of Nsol225(b-I) and Unil390 (c-III) compared to Nsv443
  • Escherichia coli Desulfovibrio vulgaris strain PT2 , Ni trosovibrio tenuis strain NV12,
  • Ni trosomonas europaea strain ATCC 19718, and Ni trosomonas strain C-56 were used as sources of nucleic acid for these experiments.
  • RNA preparation Total cellular RNA was isolated by phenol/chloroform extraction. For some of the samples, a ribosome enrichment was performed before RNA extraction. Forty ml of log phase growth E. coli or D . vulgaris strain PT2 was centrifuged at 3500 g for 10 min. and resuspended in 4 ml of 4 2 C ribosome buffer. Ribosome enrichment buffer consisted of 20 mM MgCl2, 50 mM KCl , 50 mM Tris at pH 7.5, and 5 mM ⁇ -mercaptoethanol in diethyl pyrocarbonate treated double-distilled water.
  • the cell suspension was divided between 4 screwtop microfuge tubes and 0.5 g of 0.1 mm Zr02 beads were added. The cell suspensions were disrupted for 2 min., put on ice for 5 min. , and disrupted again for 2 min. The cell suspensions were centrifuged at 14000 g for 10 minutes. The supernatant, which contained the ribosomes, was recovered and transferred to ultracentrifuge tubes. Ribosomes were pelleted by ultracentrifugation in ribosome buffer at 55,000 rpm (201,000 g average) for 50 minutes in a Beckman Optima Series TL swinging bucket rotor (Beckman, Fullerton, CA) , for a Svedberg sedimentation factor of 70S.
  • RNA transcripts DNA was extracted from E. coli , Desulfovibrio vulgaris PT2 , Ni trosovibrio tenuis NV12,
  • Ni trosomonas europaea 19718, and Ni trosomonas strain C-56 cell pastes using a guanidine/diatom method were recovered from each by PCR amplification using S-D-Bact- 0011-a-S-17 (GTTTGATCCTGGCTCAG (SEQ ID:16)) and S-D-Bact- 1492-a-A- 21 (ACGGYTACCTTGTTACGACTT (SEQ ID:17)) as primers and a premixed PCR amplification buffer (Pharmacia Biotech Inc.
  • Piscataway, NJ consisting of 0.2 mM Mg++, 2.5 mM each dATP, dCTP, dGTP, dTTP, 0.2 mM of each amplification primer, and 2.5 units of Taq DNA polymerase (Pharmacia) . Temperature cycling was done in an Idaho Technology thermocycler (Idaho Falls, ID) using 30 cycles of 15 sec at 94°C, 20 sec at 50°C, and 30 sec at 72 °C. The PCR-products were cloned in a pCR plasmid (Invitrogen, San Diego, CA) according to manufacturers instructions. Plasmids were isolated using the Wizard kit (Promega, Madison, WI) and used for in vi tro transcription of the cloned SSU rRNA genes.
  • DNA oligonucleotide probes were complementary to the SSU rRNAs and previously characterized using a membrane hybridization format. Five probes hybridize to different groups of ammonia-oxidizing bacteria within the beta-subdivision of the Proteojbacteria. S-G-Nso-190-b-A-19 (Nsol90) and S-G-Nso- 1225-a-A-20 (Nsol225) encompass all sequenced ammonia- oxidizers of the beta-subclass of Proteobacteria , probe
  • S-G-Nsm-156-a-A-19 (Nsml56) identifies members of the genus Ni trosomonas (also including Ni trosococcus mobilis)
  • probe S-G-Nsv-443-a-A-20 (Nsv443) is specific for the Ni trosovibrio/Ni trosolobus/Ni trosospira group
  • probe S-G-Nsm-653-a-A-18 (NEU23) is specific for the halotolerant members of Ni trosomonas .
  • Probes for members of genus Ni trobacter (nitrite oxidizing) were S-G-Nit-
  • RNA and DNA labeling and fragmentation Single stranded DNA was prepared by asymmetric PCR according to Ausubel et al . (1994) using a 100 times excess of the forward primer. Briefly, DNA was partially depurinated in 80% formic acid for 30 min. at 20°C, then incubated in 0.5 M ethylenediamine hydrochloride (pH 7.4) for 3 hr at 37°C, followed by 30 min. at 37°C in the presence of 0.1 M NaBH4. Fluorescein isothiocyanate was incorporated into fragmented DNA by incubation in absolute DMSO at room temperature for 1 hr.
  • RNA was fragmented by base hydrolysis and dephosphorylated with bovine phosphatase. Fragmented RNA was oxidized by NaI04 and labeled either by ethylenediamine mediated coupling of 6-carboxyfluorescein (FAM) succinamide or by direct incorporation of tetramethylrhodamine-hydrazide (TMR) . Microchip fabrication. A matrix of glass- immobilized gel elements measuring 60 x 60 x 20 or 100 x 100 x 20 ⁇ m each and spaced apart by 120 or 200 ⁇ m respectively was prepared. The polyacrylamide gel was activated by substitution of some amide groups with hydrazide groups by hydrazine-hydrate treatment.
  • FAM 6-carboxyfluorescein
  • TMR tetramethylrhodamine-hydrazide
  • Oligonucleotides were activated by oxidizing 3'-terminal 3 -methyluridine using NaI04 to produce dialdehyde groups for coupling with hydrazide groups of the gel and coupled to each micromatrix element by applying 0.5-1 nl of the activated oligonucleotide solution (100 pmol/ ⁇ l) using a specially devised robot.
  • Probe binding was quantified by measuring the fluorescence conferred by the binding of fluorescently labeled DNA or RNA (tetramethyl rhodamine or fluorescein) to the individual gel elements.
  • Hybridization and washing was controlled and monitored using a Peltier thermotable (with a working range of -5.0°C to +60.0°C) mounted on the stage of a custom-made epifluorescent microscope.
  • the microchip was hybridized at 5°C, either overnight or for 6 hr, in 2-5 ⁇ l of the hybridization buffer [33% formamide, 0.9 M NaCl, 1 mM EDTA, 1% Tween-20, and 50 mM sodium phosphate (pH 7.0)] at a concentration of DNA and RNA between 0.2-2 pmol/ ⁇ l.
  • the hybridization mixture was replaced with 5-10 ⁇ l hybridization buffer without formamide immediately prior to microscopic observation. Exposures were in the range of 0.1-10 sec depending on the signal intensity, but were typically around 1 sec.
  • a customized microchip contained oligonucleotides specific to ⁇ -thalassemia normal and abnormal ⁇ -globin genes.
  • the hybridization with PCR- amplified DNA or RNA samples derived from genomic DNA of subjects allowed unambiguous identification of a mutation in a sample to be tested. Reliability of the identification was enhanced by using simultaneous hybridization with two samples of a normal and mutated RNA stained with different fluorescence dyes and monitoring the hybridization at different wavelengths; by simultaneously measuring the melting curve for duplexes formed on a microchip, and by using a proper set of several oligonucleotides complementary to the mutated site of the DNA.
  • a microchip with 100x100x20 ⁇ m gel elements contained immobilized decadeoxyribonucleotides, that is, 10-mers that correspond to normal and mutant ⁇ -thalassemia alleles. These 10-mers discriminated mismatches less reliably than 8-mers, but were hybridized more efficiently than 8-mers. 10-mers were, therefore, preferred for this assay.
  • Table 3 shows the sequences of the allele-specific oligonucleotides immobilized on the microchips. It was expected that mismatches within the duplexes would have a much higher destabilization effect than mismatches at the terminal positions (Khrapko et al . , 1991); therefore the mutated bases were placed inside of the immobilized oligonucleotides .
  • RNA fragments were derived from PCR-amplified genomic DNA by transcription with T7 RNA polymerase (Lipshutz et al . ,
  • RNA transcripts About 100 copies of unlabeled or fluorescently labeled RNA transcripts are synthesized per DNA molecule, providing a convenient way to prepare a sufficient amount of the hybridization probes. RNA is fragmented and one fluorescent dye molecule is introduced per fragment .
  • Table 3 shows the sequences of the microchip allele specific 10-mers.
  • Oligonucleotides 1-16 of microchip II correspond to the normal and IVS 1/2 G/T allele.
  • the mutated and corresponding normal bases are placed from the 2 nd to the 9 th positions of the 10-mers from their 3 '-end.
  • the mutated bases are shown in lowercase bold letters and corresponding oligonucleotide bases in the normal allele are underscored.
  • the oligonucleotide synthesis and the microchip manufacturing were described by Yershov et al . (1996) .
  • Microchip I was successively hybridized with RNA 75 and 133 nt long without fragmentation or after fragmentation (133fr, Table 5, probes 3a and 4a) and with
  • RNA and 19-mers were labeled with TMR except for RNA probes 2a, 2b, and 6b, which were labeled with fluorescein (FI) .
  • the melting curves (FIG. 1A-B, FIG. 2) were measured simultaneously for all microchip oligonucleotides at each hybridization. These curves provided values of hybridization intensities at the discrimination temperature, Td.
  • R is the ratio of the hybridization signal of a mismatched duplex (Im) to the signal of the perfect duplex (Ip) estimated at Td in parallel for all microchip oligonucleotides.
  • R Im/Ip. d 19 -synthetic 19- deoxymers were complementary to allele specific 10-mers immobilized on the microchips.
  • Table 4 shows the effect of the position of the allelic base within 10-mers on mutation detection.
  • Microchip II contains two sets of 10-mers corresponding to the normal and IVS 1/2 T/G alleles. The microchip was hybridized with the TMR-labeled normal allele 19-mer and to an RNA 75 nt long.
  • T 0-1 is the temperature at which the hybridization signals for a microchip duplex drops to 1/10 of its initial value at 0°C.
  • - ⁇ 0-1 T 0-1 (a perfect duplex) minus T c-1 (the corresponding mismatched duplex.)
  • Fluorescently labeled RNA probes were prepared from a fragment of the ⁇ -globin gene from the first exon (Lawn et al . , 1980) .
  • PCR amplification of a 1.76-kb fragment of the human ⁇ -globin gene mapped from nucleotides -47 to +1714 was carried out with 1 ⁇ g genomic of DNA (Poncz et al . , 1982) and 50 pmol each of the forward primer: 5'- GGAGCCAGGGCTGGGCATAAAAGT-3 ' (SEQ ID:18)) (-47->-23) and the reverse primer 5 ' -ATTTTCCCAAGGTTTGAACTAGCTC-3 ' (SEQ ID:19) (+1689->+1714) .
  • the amplification was carried out in a DNA thermal cycler (GeneAmmp PCR System 2400, Perkin Elmer Corporation) in 100 ⁇ l of a buffer containing 200 mM each of dATP, dCTP, dGTP, dTTP, 2.5 mM MgCl 2 , 2 units of Taq DNA polymerase (BioMaster, Russia), 50 mM KC1, 10 mM Tris-Hcl, pH 9.0, and 0.1% Triton X-100. The reaction conditions were 30 cycles, with 45 sec at 95°C, 90 sec at 66°C, and 120 sec at 72°C. PCR product was purified from 2% low gel/ melting temperature agarose gel (NuSieve agarose, FMC) .
  • the 159 bp and 102 -bp DNA fragments were amplified with 10 ng of the 1.75 kb DNA with three nested primers, two containing T7 promoter sequence and a common reverse primer.
  • the nested primers were T7-V2L-45.
  • CACCATGGTGCACCTGACTCC-3 ' (SEQ ID:1) -44->+66); T7-V2L-103 (5 ' -GGAATTCCTAATACGACTCACTATAGGGAGGTGAACGTGGATGAAGTTGG-3 ' (SEQ ID:2); +102 - >-123 ) ; and 5 ' -TCTCCTTAAACCTGTCTTGTAACC- 3' (SEQ ID:3) (common reverse ; 153 - >+176 ) .
  • the amplification was carried out in 25 cycles (15 sec at 95°C, 30 sec at 62°C, and 30 sec at 72°C) . PCR products were purified by QIAGEN QIAquick PCR Purification Kit.
  • the PCR-amplified 159 or 102 bp DNA (4-5 ⁇ g) containing T7 promoter was transcribed with 400 units of T7 RNA polymerase (Promega) to produce 133 and 75 nt long RNA in 80 ⁇ l of buffer containing 300 mM HEPES , pH 7.6 , 30 mM MgCl 2 , 16 ⁇ g of BSA, 40 mM DTT, 30 units of Rnasin
  • Fragmentation of 10-100 ⁇ g of RNA to an average length of 20- to 40-mers was carried out in 50 ⁇ l of 0.1 M KOH for 30 min. at 40°C. Then 5 ⁇ l of 1M HEPES, pH 7.6, and 15 ⁇ l of 1% HC0 4 were added at 4°C. The pellet of potassium perchlorate was removed by centrifugation and RNA was precipitated by 10 volumes of 2% LiC10 4 in acetone. The RNA was washed twice with acetone and dried for 20-30 min. at room temperature.
  • RNA deproteinization and purification was carried out as described herein.
  • RNA was oxidized in 20 ⁇ l of 10 mM sodium periodate for 20 min. at room temperature.
  • RNA was precipitated with acetone.
  • a 10 molar excess of 10 mM TMR-hydrazine in 10% acetonitrile was added to oxidized RNA fragments in 20 ⁇ l of 20 mM sodium acetate at pH 4.0.
  • the reaction mixture was incubated 30-40 min at 37°C, and the hydrazide bond between the RNA and dye was stabilized by reduction with freshly prepared 1.5 ⁇ l of 0.2 M NacNBH 3 and incubated for 30 min. at room temperature.
  • RNA was labeled by incorporation of fluorescein-UTP during the transcription with Ambion MEGAshortscript kit according to the manual. The hybridization of fluorescently labeled RNA
  • Table 4 summarizes the results of hybridization of the diagnostic microchips with 1) RNA probes derived from a number of homozygous and heterozygous ⁇ -thalassemia patients; and 2) with corresponding 19-mers.
  • the table shows the Td for perfect duplexes formed on each microchip oligonucleotide.
  • the relative intensities, R, of the hybridization signals for a different microchip oligonucleotides in Table 3 are normalized to the signals for a perfect duplex at the Td (estimated as 1.0) . In most cases the ratios for mismatched duplexes are less than 0.1 and close to 0.
  • oligonucleotides corresponding to IVS V2 T/A and IVS V2 T/G mutations that show strong mismatched signals upon hybridization with non-corresponding samples of IVS (N) and IVS Vz T/A RNA's, respectively (Table 5, la, 2b, 4a, 6a and 6b) .
  • the relative intensities of these mismatched signals can be significantly decreased by choosing the proper oligonucleotides for immobilization.
  • RNAs 75 nucleotides (nt) long Table 5, probes la, and 6a)
  • 133 nt long probes 2a and 6b
  • 133 nt long probes 2a and 6b
  • the intensities of the hybridization signals after fragmentation are increased by about 5 times and the time of hybridization is decreased from several hours to a tens of minutes .
  • RNA probes diffuse more slowly into the gel and can form stable secondary structures or aggregates . These factors interfere with their hybridization with rather short immobilized oligonucleotides. Thus, the fragmentation seems to be an essential step in sample preparation, since it enhances and speeds the hybridization.
  • the reliability of identification of mutations and base changes can be enhanced by the use of a multicolor fluorescence microscope (Yershov et al . ,
  • the tested RNA is marked by one fluorescence label and is hybridized with a microchip in the presence of a normal allele sample labeled with a different dye.
  • the pattern and the ratio of hybridization measured with the two dyes will be similar for all microchip oligonucleotides except for those that correspond to different allele bases, i.e., mutations.
  • Table 4 shows the results of such an experiment. The patterns of hybridization detected at two wavelengths are very similar.
  • the immobilized 10-mers matching the mutations IVS 1-2 T/G, IVS 1-2 T/C, and IVS 1-2 T/A are hybridized rather strongly with some RNA probes that correspond to other alleles. Different structural factors in RNA could cause this hybridization. The effect of these factors can be minimized by placing a variable IVS 1-2 base into different positions of the 10-mers. The results of such experiments are shown in Table 4.
  • Microchip II was successively hybridized with fragmented 75-nt-long RNA or with a synthetic DNA 19-mer, both corresponding to the normal allele.
  • Microchip II contained two similar sets of eight overlapped immobilized 10-mers that are complementary either to a normal allele or to IVS 1-2 T/G allele.
  • the allele specific bases A for the first set and C for the second set are located in these 10-mers in all internal positions from the 2 nd to the 9 th . These bases form perfect A-T or mismatched A-G base pairs, respectively.
  • the stability of the perfect and mismatched duplexes formed on the microchip is determined as T 0-1 the temperature at which the initial hybridization signal of the duplex is decreased to one-tenth of the original intensity.
  • ⁇ 0-1 corresponds to the difference in T Q 1 between the perfect and similar mismatched duplexes.
  • a better discrimination of the perfect and mismatched duplexes is reflected in higher values of ⁇ 0-1 .
  • the discrimination efficiency ( ⁇ T) was lower for hybridized RNAs than for the 19-mers.
  • RNA transcripts of PCR- amplified DNA with oligonucleotide microchips allows the reliable identification of base changes and discrimination of homozygous and heterozygous ⁇ -thalassemia mutations in the genomic DNA of patients.
  • RNA transcribed from PCR-amplified DNA provides an easier method for preparing a sufficient amount of labeled, single-stranded samples than the use of DNA prepared by PCR amplification. RNA can be fragmented and one fluorescent dye molecule can be introduced per fragmen .
  • Example 7 Use of a Customized Microchip Biosensor to Detect Gene Expression
  • Gene expression is one of the central themes in modern molecular biology. DNA from well studied genetical sources has already been systematically sequenced. For these sequences hybridization procedures are successfully used to estimate a level of differential gene expression. The results of this estimation are useful for understanding fundamental mechanisms of development biology, embryology and treatment of genetic and infectious diseases .
  • microchip biosensor hybridization was carried out with ssDNA fragments isolated from six different genes:
  • G3PDH glyceraldehyde 3 -phosphate dehydrogenase
  • HTR human transferrin receptor
  • B2M human ⁇ 2 -microglobulin
  • IL1R human interleukin-1 receptor
  • IGR human interferon ⁇ receptor
  • a customized microchip containing immobilized 60 b oligonucleotides, having at the 3 ' -terminal position 3-methyluridine residues, corresponding to five housekeeping genes (G3PDH, HTR, B2M, IL1R and NF-kb(p50)) (CLONTECH catalog 94/95 "Tools for the Molecular
  • ssDNA fragments complementary to immobilized oligonucleotides were synthesized by asymmetric PCR amplification (using only one primer) with fluorescently labeled nucleotide triphosphates ⁇ FUORscript T7 ,
  • FIG. 8 demonstrates hybridization on the microchip. Intensity of fluorescence in each spot depends on the amount of immobilized oligonucleotide and on the length of the DNA fragment in the spot.
  • Buffer A 50% formamide, 10% dextran sulfate, 1% SDS, 50 mM sodium phosphate at pH 7.4, 750 mM sodium chloride, 5 mM sodium EDTA
  • ssDNA with a concentration of 0.5 pmol/ ⁇ l (approximately 0.05 ⁇ g/ ⁇ l) was incubated for about 6 - 12 h at room temperature, washed briefly with H 2 0 and analyzed with a fluorescent microscope. Before rehybridization the microchip was treated in Buffer B (50% formamide, 1% Tween 20) for 30 min. at 50°C to completely remove hybridized ssDNA.
  • Example 8 Use of a Customized Microchip Biosensor to Detect HLA Polymorphisms
  • HLA locus class I and class II genes
  • IDDM Insulin - Dependent Diabetes Mellitus
  • autoimmune diseases such as rheumatoid arthritis and pemphigus vulgaris - a skin disease which causes severe blistering.
  • IDDM Insulin - Dependent Diabetes Mellitus
  • autoimmune diseases such as rheumatoid arthritis and pemphigus vulgaris - a skin disease which causes severe blistering.
  • the high level of polymorphism of HLA has been shown to be useful for identification of individuals determining the group of risk for some diseases. HLA typing is particularly crucial for matching donors for transplants. It is also proposed for infertility work- ups .
  • the present invention provides a method which allows an array of immobilized 8-12 bp- long oligonucleotides to form an oligonucleotide microchip thereby facilitating identification of HLA DQAl allies.
  • a customized microchip, containing an array of eighteen PAA - gel immobilized (lpmol of each) short oligonucleotides has been produced for hybridization with fluorescently labelled complementary HLA DQAl DNA or RNA probe for allele identification.
  • 18 decamers were loaded on the chip in the following order, from left to right:
  • the sequence of the oligos used was as shown in FIG. 9.
  • the oligonucleotides immobilized on the microchip are complementary to the sense strand of different alleles of DQAl DNA and some control oligos .
  • a microchip with 20 oligonucleotides was manufactured for partial identification of 15 different alleles in the HLA DQAl region. PCR was used to prepare 229 bp (starting from codon 12 to codon 87) DNA fragments of the polymorphic second exon of the DQAl gene from human genomic DNA.
  • Nested primers were used 2DQAAMP-A: 5 ' - a t ggt gta aac ttg tac cag t ; and 2DQAAMP- B:5'tt ggt age age ggt aga gtt g.
  • Nested PCR primers were: T7-2DQAAMP-A and primer B. The first primer containing the promoter for T7 RNA polymerase and PCR product were used for in vi tro transcription. RNA probes were identical to the coding DNA strand. RNA was fragmented, labelled with fluorescein and used for hybridization with the microchip.
  • FIG. 10 shows the hybridization results and presents schematically the HLA DQAl - chip for allele identification.
  • three diagonally placed oligos (11-0101/0104 allele specific; 6-specific for 0101,01021,01022,0103,00104; 17-correspond to all alleles, except 0502) gave a positive hybridization signal, and are observed as three diagonally placed bright fluorescence spots .
  • the probes were identified as the 0101 or 0104 allele (both alleles are identical in the second exon) . All other oligos yielded much weaker fluorescence signals compared with those described above, because none of them contain sequences complementary to alleles 0101 and 0104. On the other hand any allele different from 0101 or 0104, reveals another set of hybridization signals.
  • the brightest fluorescent squares on the chip were:
  • Oligo# 4 which is 03011 or 0302 specific; oligo# 8 is Taq polymerase-specific artifacts; oligo# 18-belong to alleles 0101-05011; oligo 11-0101,0104 allele specific; 17 - corresponds to all alleles, except 0502; g4 is a fluorescent control oligo; #13 - mismatch to #18. All other chip elements showed significantly less intensive fluorescence. The genotype identified by these probes has a 0101/0104-0302/03011 heterozygote .
  • Example 9 Use of a Customized Microchip Biosensor to Detect the Lyme Disease Spirochetes
  • Bacteria belonging to the species Barretia burgdorferi and related species of tick-borne spirochetes are capable of causing human and veterinary disease.
  • Nucleic acid probes are available to detect bacteria causing Lyme disease. These bacteria cannot be identified by standard microbiological methods, although immunological tests are available.
  • oligonucleotides are prepared according to eisburg (1995) and added to a micromatrix designed for use in detecting Lyme disease in a clinical sample.
  • Example 10 Use of a Customized Microchip Biosensor to Detect Salmonella In Food Samples
  • Salmonella presence is detected most commonly by preparing cultures according to standard microbiological laboratory procedures, and testing the cultures for morphological and biochemical characteristics. After about 48 hours after collection of a sample testing begins and takes several days to complete. However, RNA and DNA probes for Salmonella testing are available. Using the methods of the present invention, oligonucleotides are prepared according to Lane et al . (1996) incorporated herein by reference and added to a microchip designed for use in detecting Salmonella in food samples by distinguishing rRNA of Salmonella from non-Salmonella.

Abstract

Biosensors are constructed using customized micromatrices to design a microship. The microchip contains an arrangement of oligonucleotides designed to provide information on oligonucleotide sequences in a sample to be tested by the ability of the oligonucleotides in the nucleic acid sample to hybridize with oligonucleotides on the microchip. Biosensors are used to detect microorganisms in the environment, in biological samples and in food. Biosensors are also used to diagnose genetic defects, to identify polymorphisms, and to monitor quantitative gene expression.

Description

CUSTOMIZED OLIGONUCLEOTIDE MICROCHIPS AS MULTIPLE BIOSENSORS
This invention relates to using customized oligonucleotide microchips as biosensors for the detection and identification of nucleic acids specific for different genes, organisms and/or individuals in the environment, in food and in biological samples.
"Environment" includes water, air and soil. Biological samples include blood, skin, tumors amniotic fluid, tissues, cells and cell cultures. Detection of sequences in nucleic acids is used to identify microorganisms in a sample, to diagnose genetic defects or polymorphisms, to detect gene expression and for forensic studies.
Differences in nucleotide and amino acid sequences may be exploited to analyze environmental, food or biological samples. Detection and identification of microorganisms is important for clinical purposes and for determination of contaminated food, air, water or soil. Studies in environmental microbiology are often limited by the inability to unambiguously identify and directly quantify the enormous diversity of natural populations. This problem is now changing with increasing use of molecular techniques to directly measure different genetic features. (Mobarry et al . , 1996; Stahl , 1995;
Wagner et al . , 1995) For example, DNA probes are now commonly used to detect by hybridization, genes encoding proteins involved in specific catabolic functions, and to resolve different genetic populations in the environment. In particular, the use of group- specific DNA probes complementary to the small subunit (SSU) 16S rRNA has provided a comprehensive framework for studies of microbial population structure in complex systems. Sequencing of this subunit revolutionized microbial classification and led to the discovery of archebacteria . (Woese, 1987) A large number of the sequences for different organisms has been collected. (Maidak et al . , 1996) Every microorganism species is characterized by a specific
DNA sequence within a variable region of its ribosomal RNA gene or other genes. A highly efficient procedure for microorganism classification and for construction of their evolutionary trees is based on these observations. Identification of specific sequences in ribosomal DNA is a reliable microbial analysis that can be carried out by direct DNA sequencing. However DNA sequencing is a rather complicated, expensive and time consuming procedure to use for serial microbial analysis on a commercial scale for environmental or medical applications. Consequently, new methods are needed to make sequence matching commercially feasible.
A nucleic acid hybridization is a highly specific and sensitive procedure that allows a specific sequence to be detected and identified among other millions of sequences in a genome of higher organisms, or among a mixture of different organisms . The principle of hybridization is that sequences hybridize as a function of the similarity of their linear nucleotide sequence. The hybridization of DNA or RNA extracted from even a very complicated mixture to a specific oligonucleocide probe has resulted in unambiguous identification of specific microorganisms in an environmental sample, for example. In the course of such an analysis, RNA or DNA is extracted from a sample of microorganisms isolated from water solutions, air or soil, immobilized on a filter and then hybridized successively with several oligonucleotide probes for different microorganisms. However, for this purpose, the sample needs to be checked for the presence of hundreds or thousands of different oligonucleotides corresponding to various microorganisms which is prohibitively laborious and expensive using present methods.
The scope of applications of nucleotide hybridization is often limited by the nature of the assays, generally involving the independent hybridization of multiple environmental samples to multiple DNA probes. In addition, some detection assays require amplification of the target nucleic acid, for example, via PCR. This may contribute to quantitative biases. Thus, there is need for assays that provide for greater sample through-put capacity and greater sensitivity.
Another area in which specific DNA or RNA sequences are of interest is mutation and polymorphism analyses . The number of base changes discovered (mutations) in different genes is growing rapidly. These changes are associated with genetic diseases, with disease predispositions and cancers, with develop- ment of drug resistance in microorganisms, and with genetic polymorphisms . Polymorphisms are useful for determining the source of a sample, e.g. in forensic analyses. Polymorphisms such as in the HLA system are essential to predict success of tissue transplants. The ability to simultaneously analyze many mutations in a gene in a simple, fast, and inexpensive way is essential in clinical medicine and this need has stimulated the development of different methods for screening mutations, but all have serious limitations . Hybridization of filter- immobilized DNA with allele-specific oligonucleotides was suggested as a way to screen for mutations. (Conner et al . , 1983) However, the number of alleles that can be assayed at one time is limited, the filters are usable only for a few times, and there is little opportunity for complex analysis . A possible solution to large scale hybridization is to use microchips for DNA sequence hybridizations (SHOM, sequencing by hybridization with oligonucleotides in a microchip) (e.g. Khrapko, 1996; Yershov, 1996) . The development of an array of hundreds or thousands of immobilized oligonucleotides, the so-called "oligonucleotide chips", permits simultaneous analysis of many mutations (for a review, see Mirzabekov, 1994) . Such arrays can be manufactured by a parallel synthesis of oligonucleotides (Southern et al . , 1992; Fodor et al . , 1991; Pease et al . , 1994;
Matson et al . , 1995) or by chemical immobilization of presynthesized oligonucleotides (Khrapko et al . , 1991;
Lamture et al . , 1994; Ghu et al . , 1994). Glass surfaces (Southern et al . , 1992; Fodor et al . , 1991; Ghu et al . , 1994), glass pores (Beattie et al . , 195), polypropylene sheets (Matson et al . , 1995), and gel pads (Khrapko et al . , 1991; Yershov et al . , 1996) have been used as solid supports for oligonucleotide immobilization. However "Oligonucleotide array technology has not yet lived up to its promise."
Southern, 1996 p. 115. Some of the deficiencies are unpredictability of the results, lack of knowledge of optimum conditions, and failure to demonstrate accuracy and commercial feasibility. SUMMARY OF THE INVENTION
This invention embodies applications of oligonucleotide microchip technology wherein the microchip is a biosensor and customized oligonucleotide microchips are designed for specific applications of nucleic acid hybridization. Hybridization is a process by which, under defined reaction conditions, partially or completely complementary nucleic acids are allowed to join in an antiparallel fashion to form specific and stable hydrogen bonds .
Aspects of the invention include improved predictability, increased accuracy, and standardized factors for detection and identification of nucleotide sequences. The improvements result from optimizing conditions, methods and compositions for microchip hybridization. Ordered schemes are followed so that much information can be obtained from a single scan of a microchip to detect hybridization of oligonucleotides in a sample to be investigated. Samples include air, water, soil, blood, cells, tissue, tissue culture and a food. An aspect of the invention is that the same microchip can be used for hybridization for more than 20-30 times, without any noticeable deterioration of the hybridization signal. Customized sets of microchips are obtained for specific applications. Also, parallel hybridization of nucleic acids in a sample to many oligonucleotides on a microchip is possible, allowing replication and standardization. For example, the sequence diversity of SSU rRNAs recovered from different microbial populations of varying abundances is analyzed by a single hybridization to a microchip. A large number of HLA alleles, are assayed by a single hybridization to a microchip. The invention relates a method for identifying a nucleotide sequence in a sample using a microchip, said method comprising: a) extracting nucleic acids from said sample ; b) providing a customized matrix of oligonucleotides on the microchip designed to identify the sequence in the sample; c) hybridizing said extracted nucleic acids as such or after amplification on said microchip; and d) identifying the nucleotide sequence represented in said sample by comparing the identity of the oligonucleotides which hybridized to the sequence and the oligonucleotides not hybridized. The nucleic acids include DNA, mRNA, 16S rRNA sequences and other RNA species.
Customized oligonucleotide microchips are aspects of the invention. The microchip includes a gel -matrix affixed to a support, said matrix is formed by a plurality of gel pad element sites. The number of sites is determined by the number of oligonucleotides in the array. Each gel element contains one chemically immobilized oligonucleotide of a desired sequence, length and concentration; the gel elements being separated from one another by hydrophobic glass spaces and the gel portions having a vertical height above the plane of the interstitial spaces of generally not more than 30 μm.
The invention relates screening nucleic acid preparations for genes, RNA transcripts or any other unique nucleotide sequences, for example those that encode microbial 16S ribosomal RNAs . Ratios of DNA/RNA or any other unique nucleotide sequences specific for certain types of organisms are suitable. Multiple labeling allows simultaneous detection and quantitative comparison of different nucleic acid sequences that are hybridized to a microchip.
The methods of the present invention include labeling the oligonucleotide sequence in said sample before bringing it in contact with the array. A suitable label is a fluorescent dye. A plurality of different dyes may be used concurrently. Oligonucleotides on a customized microchip include those complementary to the beta globin gene, sequences specific for Salmonella , or polymorphic HLA allele sequences.
An oligonucleotide microchip for the detection and classification of nitrifying bacteria has a customized design wherein identifying labels in the cells of the microchip refer to oligonucleotides selected from a class of bacteria, and the selection is designed to answer specific questions regarding classification.
An embodiment of an application of the present invention is detecting and identifying microorganisms in samples obtained from the environment, e.g. water, air or soil samples to check for pollutants; biological samples obtained for medical diagnosis; or food samples to check for contamination. Other applications include forensic testing to identify DNA in samples obtained for criminal investigations, and detection of chromosomal fragments, or single gene mutations e.g. for diagnosing genetic diseases such as β-thalassemia or types of cancers. Tissue typing for polymorphic HLA alleles for transplantation or studying human diversity is facilitated.
The nucleic acid preparations are made from samples collected in any type of environment, where detection and identification of the microorganisms in that environment is of interest, or where it is likely that new (previously unidentified) organisms may be discovered. The volume of each microchip is great enough to accommodate a high surface concentration of probes, allowing a large dynamic range for measurement.
DNA and RNA molecules in a sample can be separated from each other during their isolation and labeled with different fluorescent dyes. These RNA and DNA molecules are simultaneously hybridized with oligonucleotides on a microchip that is specific to the sample to be tested. The quantitative monitoring of the simultaneous hybridization of differently labeled DNA and RNA with a microscope that can discriminate multicolors at several wave lengths allows the calculation of DNA/RNA ratios in the sample. For bacterial samples, this ratio determines the state of vitality and physiological activity of the bacterium. In an embodiment, the ratio of RNA/DNA is used to discriminate the dead bacterium cells and spores from the active state of microbial growth. In the same way, a DNA or RNA molecule of a bacterial strain stained with one dye can be added in a calculated amount as an internal standard to a sequence or sequences under investigation in which the sequences being investigated stained with a different (second) dye. The fluorescence measurements of hybridization intensities at different wave lengths for the standard and investigated sequences (probes) allow relative quantitative ratios to be determined.
Hybridization on microchips allows unambiguous typing of different groups of chosen bacteria in a sample. Microchip hybridization is a simple, fast, inexpensive and reliable method for bacterial typing.
An aspect of the invention is that there is no limitation on the number of sequences that can be checked or the number of types of microorganisms that can be detected. Instead of multiple sequential hybridizations with different probes of, e . g. a 16S rRNA preparation, only one round of hybridization is required to find out what different sequences are in a sample. The volume of hybridizations is dramatically reduced and the assay requires much less RNA or DNA compared with standard techniques . An advantage is that culturing of bacteria and gene amplification can be avoided.
Methods of the invention significantly reduce sample preparation time, avoid the culturing of organisms collected from field situations, and allow the identification of all species of microorganisms contained in a particular sample.
For example, oligonucleotides complementary to small subunit rRNA sequences of selected microbial groups, encompassing key genera of nitrifying bacteria, were shown to selectively retain labeled target nucleic acid derived from either DNA or RNA forms of the target sequences. Methods and compositions of the present invention discriminate among the Genera, Ni trosomonas , Ni trobacter and Ni trosovibrio sp . using fluorescently labeled nucleic acid probes that hybridize to 16S rRNA sequences. Each species has specific DNA sequences within the variable region of its rRNA genes. Since the rRNAs are naturally amplified, often present in thousand of copies per cell, they provide greater sensitivity, eliminating the need for amplification in many applications.
The invention facilitates identification of organisms from environmental samples in a faster, and more economical approach than presently available. In addition, new species may be discovered that would be highly informative regarding taxonomic status of known as well as newly discovered organisms.
A diagnostic assay of the present invention for a mutation in a gene, includes the following steps: a. designing a customized oligonucleotide microchip biosensor comprising oligonucleotides that hybridize to a gene having the mutation; b. contacting a nucleic acid sample to the customized oligonucleotide microchip biosensor under conditions that allow hybridization of the nucleic acid to the microchip; and c. determining whether hybridization occurs from which observation the presence of the specific nucleic acid sequence is inferred.
For diagnostic assays for genetic diseases, sequence analysis of DNA is carried out by hybridization of PCR amplified DNA or its RNA transcripts with oligonucleotide array microchips. Polyacrylamide gel pads containing allele-specific immobilized oligonucleotides are fixed on a glass slide of the microchip. The RNA transcripts of PCR-amplified genomic DNA are fluorescently labeled by enzymatic or chemical methods and hybridized with the microchip. The simultaneous measurement in real time of the hybridization and melting curves on the entire oligonucleotide array is carried out with a fluorescence microscope equipped with CCD camera. The monitoring of the hybridization specificity for duplexes with different stabilities and AT content is enhanced by its measurement at optimal discrimination temperatures on melting curves. Microchip diagnostics are optimized by choosing the proper allele-specific oligonucleotides from among the set of overlapping oligomers. The accuracy of mutation detection can be increased by simultaneous hybridization of the microchip with at least two differently labeled samples of normal and mutated alleles, and by parallel monitoring their hybridization with a multi-wavelength fluorescence microscope. The efficiency and reliability of the sequence analysis was demonstrated by diagnosing β-thalassemia mutations and HLA polymorphisms .
Determining levels of gene expression is an aspect of the invention. Because the methods of the present invention require only a simple procedure of hybridization and because only one round of hybridization is necessary, it is fast and inexpensive. Because the invention allows a lot of information to be obtained from one experiment, it is efficient. The invention is reliable because the microchips are reusable. There is no waste of hybridization probes, therefore the microchip hybridization is inexpensive and non-isotopic detection simplifies all procedures. Effective and precise sequence analysis by the hybridization of a probe with rather short microchip- immobilized oligonucleotides depends on many factors. Major factors are the reliability of the discrimination of perfect duplexes from duplexes containing mismatches, differences in stability of AT- and GC-rich duplexes, the efficiency of the hybridization, and simplicity in the preparation of the labeled samples for hybridization.
Identification of base variations is significantly improved by parallel measuring of the melting curves of the duplexes formed on the entire oligonucleotide array, as well as by monitoring the simultaneous hybridization of two differently labeled samples at two wavelengths and by choosing proper allele-specific oligonucleotides.
Other factors to be considered for operation of the invention include (1) regulating the flow of the fluid containing a sample to be tested over the microchip during the hybridization; and (2) control of the temperature of the microchip gel layer and the fluid layer, in a differential manner, by placing a cooling and heating apparatus adjacent to the gel layer and the top fluid layer. The gel layer temperature is controlled in a uniform or gradient manner by a heating/cooling device attached to the glass plate substrate of the gels.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows non-equilibrium melting curves of duplexes of RNA with microchip oligonucleotides. FIG. 2 shows an example of four melting curves for 75 -nt- long RNA fragments hybridized with the microchip oligonucleotides. The RNA was derived from a patient having the IVS 1/2 T/A mutation in the β-globin gene. The curves were normalized to the initial hybridization signals. Melting curves 1 and 3 correspond to perfect duplexes; curves 2 and 4 correspond to duplexes containing internal T-T or G-T mismatches, respectively. The curves for the perfect and mismatched duplexes are shifted by about 10 °C from each other.
FIG. 3 shows hybridization of fluorescein labelled 16S rRNAs to a microchip. The microchip with immobilized probes (see Table 1 and Table 2) was hybridized sequentially to in vi tro transcribed 16S rRNA of Ni trosovibrio tenuis (A), Ni trosomonas europaea
(B) , E. coli (C) , and with E. coli rRNA recovered from isolated ribosomes (D) . The panels to the right display the number of mismatches between each probe and the RNA. FIGS. 4A and 4B show hybridization of the mixture of differently labelled E. coli and
Ni trosovibrio tenuis rRNAs to the microchip at 10 °C and
40°C, measured simultaneously by multicolor detection. A. The microchip was hybridized with a mixture of fluorescein labelled Ni trosovibrio tenuis and tetramethylrhodamine labelled E. coli 16S rRNA and washed serially at the indicated temperatures, a.u. - arbitrary units of fluorescence intensities. B. The ratio of the hybridization intensities of Ni trosovibrio tenuis (INt) to E. coli (IE.coll) 16S RNA measured at 10°C and 40°C. R=(INt/IE coll) .
FIG. 5 illustrates the concentration effect of the immobilized oligonucleotides on the hybridization intensities. A microchip with different concentrations of immobilized oligonucleotides was hybridized with N. tenuis 16S rRNA labelled with fluorescein and washed at 20°C. Curve 1 corresponded to Nsv443 (nitrosovibrio-like) probe, curve 2 - Bac338 (Bacteria) , curve 3 - Nsol225 (ammonia oxidizers) , curve 4 - Unil390 (all life) , and curve 5 - Nsm-156
(nitrosomonas) , a.u. - arbitrary units of fluorescence intensities .
FIG. 6 shows the sequences of β-globin alleles specifying oligonucleotides that were immobilized on a microchip.
FIG. 7 shows the experimental design to detect β-globin mutations using oligonucleotide microchips .
FIG. 8 shows results of gene expression studies.
FIG. 9 shows 18 short HLA oligonucleotides.
FIG. 10 shows HLA oligonucleotides hybridized to the microchips .
DESCRIPTION OF THE PREFERRED EMBODIMENT
This invention relates to using customized oligonucleotide microchips as biosensors for the detection and identification of nucleic acids specific for different genes, organisms and individuals in the environment, in food and in biological samples. "Environment " includes water, air and soil. Biological samples include blood, skin, tumors amniotic fluid, tissues, cells and cell cultures. Detection of sequences in nucleic acids is used to identify microorganisms in a sample, to diagnose genetic defects or polymorphisms, to detect gene expression and for forensic studies.
A nucleic acid hybridization is a highly specific and sensitive procedure and allows a specific sequence to be detected and identified among other millions of sequences in a genome of an organism. However, nucleic acid hybridization is a useful but quite a cumbersome procedure . This drawback can be overcome by using oligonucleotide microchips as biosensors for different microorganisms. Within a small area of a few square millimeters or centimeters, hundreds and thousands of synthetic oligonucleotide probes are immobilized that are specific to ribosomal DNA or to other specific nucleic acids. Subsequent hybridization of a DNA or RNA molecule to the microchip enables a menu of oligonucleotides to be identified in a sample. For bacterial assays, pure culture microorganisms, purified target nucleic acid or even synthetic oligonucleotides are useful as internal standards, serving to estimate the efficiency of nucleic acid isolation or the absolute amount of target nucleic acid recovered.
The customized oligonucleotide microchips are produced by chemical immobilization of presynthesized oligonucleotides, or by direct synthesis of oligonucleotides on a microchip. If a microchip contains rather long oligonucleotides, the former methods are the methods of choice because before immobilization, the oligonucleotides are purified and checked for their quality.
Methods and technologies have been developed for microchip manufacturing, hybridization of fluorescently labeled DNA and RNA with the microchips and monitoring the hybridization with a fluorescence microscope equipped with CCD-camera, computer and proper software (see U.S. Pat. No. 5,552,270 herein incorporated by reference) .
The oligonucleotide microchips consist of many polyacrylamide gel pad elements generally of the size of 40x40x20 μm and larger. The elements are chemically fixed on a glass surface. Each microchip gel element contains a specific presynthesized oligonucleotide that is immobilized through a covalent bond. Hundreds of microchips containing hundreds and thousands of different immobilized oligonucleotides can be manufactured by a specially devised robot . The gel array also offers several advantages over formats using an in si tu synthesis of the oligonucleotide array. The synthetic oligonucleotides are purified by gel electrophoresis or HPLC prior to immobilization on the microchip. This provides for stringent quality control of oligonucleotide purity and insures high specificity. The polyacrylamide gel support has a capacity of immobilized oligonucleotides from 0.03 pmol up to 10 pmol per 100x100x20 μm gel pad. This offers improved quantification and better discrimination between perfect and mismatched duplexes. It also provides a way to normalize differences in hybridization signal intensities .
Oligonucleotide microchip technology for sequencing by hybridization is available to identify the presence of microorganisms in a sample of any type, or to find new species . As shown in the examples herein, the hybridization of DNA or RNA extracted from even a very complicated mixture to a specific oligonucleotide probe has resulted in unambiguous identification of microorganisms. The nucleotide sequence of the microorganisms for genes encoding a small subunit of ribosomal 16S rRNA forms the basis for a microchip biosensor. Instead of direct sequencing of the gene, hybridization analysis of DNA or RNA samples with oligonucleotides specific for the microorganisms is performed. This new technology provides efficient microbial analysis and environmental monitoring. Fluorescently labeled DNA and RNA samples from microorganisms are hybridized with microchips containing oligonucleotides specific for several microorganisms. These microorganisms are reliably identified by microchip hybridization. Microorganism biosensor technology is developed, customized microbial oligonucleotide microchips are produced by methods of the present invention, and methods are developed for simultaneous quantitative and qualitative microchip analysis of hundreds and thousands of microorganisms in a sample and for discovery of new ones .
Other applications include detection of genetic mutations such as are characteristic of hemo- globin disorders; detection of genetic polymorphisms such as HLA; investigation of gene expression; detection of causative agents of diseases; forensic studies; and detection of microbial pollutants.
EXAMPLES
The following examples are presented as illustrations of aspects of the invention, rather than limitations on the invention.
Example 1 : Preparation of an Oligonucleotide Microchip Biosensor
Oligonucleotides are synthesized using a 394 DNA/RNA synthesizer (Applied Biosystems) . The synthesis of oligonucleotides for immobilization began with 3 -methyluridine at the 3 ' -terminal position. In one embodiment, fluorescently labeled RNA was prepared using T7 RNA polymerase. Template DNA (133 and 75 bp long) for in vi tro transcription was prepared by PCR amplification with the nested primers T7V2L-45, 5'-
GGAATTCCTAATACGACTCACTATAGGGACACCATGGTGCACCTGACTCC-3 ' (SEQ ID:1) , as well as with the common reverse primer T7-V2L-103 5'-
GGAATTCCTAATACGACTCACTATAGGGAGGTGAACGTGGATGAAGTTGG- 3 '(SEQ ID: 2) and 5 ' -TCTCCTTAAACCTGTCTTGTAACC-3 ' (SEQ ID: 3) . Templates were purified using a QIAquick PCR purification kit (QIAGENE) according to the manufacturer's protocol. The RNA polymerase reaction was performed using the MEGAshortscript™ T7 kit (Ambion) with fluorescein 12-UTP (Molecular Probes) . Fluorescently labeled ssDNA (single stranded DNA) fragments were prepared by single primer reamplifica- tion.
A polyacrylamide gel micromatrix was prepared by photopolymerization of a solution of 4% acrylamide (acrylamide/bisacrylamide 19/1), 40% glycerol , 0.0002% methylene blue, and 0.012% TEMED in 0.1 M sodium- phosphate buffer, pH 7.0. The mixture was applied to an assembled polymerization chamber illuminated with U.V. light.
Two types of microchip matrices (micro- matrices) were routinely prepared with gel pad elements of about 60x60x20 μm and 100x100x20 μm that were spaced by 120 and 220 μm, respectively. About 1 nl of activated oligonucleotide solution was transferred to a gel element using either a robot or a simple manual device.
The device includes a Peltier thermostated pin placed under a binocular lens in conjunction with a micromanipulated holder, a power supply, an a refrigerated circulator. The manufacture of microchips of gel- immobilized oligonucleotides basically consists of three steps; shaping the desired topology of oligonucleotides on a gel micromatrix; loading microvolumes of oligonucleotide solutions onto the micromatrix, and immobilizing within the gel oligonucleotides containing the active 3' or 5' terminal aldehyde or amine groups. To avoid the exchange of different oligonucleotide solutions applied on adjacent gel pads, the pads are separated on the micromatrix by a hydrophobic glass surface. Two-dimensional scribing or laser evaporation is used for micromatrix preparation, but these procedures require rather complex equipment and experienced personnel. The photopolymerization method significantly simplifies the procedure and makes it accessible to a biochemical laboratory. Microfabrication by mask-directed photopolymerization (e.g., a photoresist method in microelectronics) is a well developed technique. From several acrylamide photopolymerization techniques tested, modified - methylene - blue induced photo- polymerization produced the best results for micromatrix manufacture. The gel matrix consists of gel pads photopolymerized on a glass slide. The gel pads are formed according to the mask topology due to the lack of photopolymerization in places covered by a nontransparent grid.
The microchip is manufactured by applying the activated oligonucleotide solutions onto the micro- matrix of gel elements containing active hydrazide or aldehyde groups . A simple device exists for manual loading of up to 100 different oligonucleotides on a micromatrix. The transfer is carried out by the hydrophilic upper surface of a pin that is first immersed into, and is wetted with, an oligonucleotide solution, and then is withdrawn from the solution and brought into contact with the gel surface. This transfers about 1 nl of oligonucleotide solution with a reproducibility of ±10%. The temperature of the pin is maintained near the dew point of the ambient air to avoid the evaporation of this microvolume solution in the course of transfer. Example 2 ; The hybridization of microchips with DNA and RNA
Fluorescently labeled DNA or RNA (5 μl , 0.1-1 pmol/μl were hybridized to a microchip at -t-5°C in a hybridization buffer containing 1 M NaCl, 1 mM EDTA, 1% Tween-20, and 10 mM sodium phosphate at a pH of 7.0, for between about 2-24 h. The microchip was covered with a cover glass or a Teflon sheet so that a 300-um space is above. Then the hybridization solution containing DNA or RNA fragments was substituted with 10 μl of cooled hybridization buffer. The microchip with the cover glass was placed on a thermostabilized table. Hybridization was monitored quantitatively using a specially constructed multicolor epifluorescent microscope with a 4x4 mm observation field equipped with a CCD camera and suitable software.
Example 3 : Analysis of Melting Curves
The polyacrylamide gel used on a microchip provides more than 100 times higher capacity for three- dimensional immobilization of oligonucleotides than does a two-dimensional glass surface. The high concentration of immobilized oligonucleotides facilitates the discrimination of mismatched duplexes and enhances the sensitivity of measurements on the microchips. This allows the use of a CCD-camera- equipped fluorescence microscope (Yershov et al . , 1996) although it is less sensitive than laser scanning systems (Lipshutz et al . , 1995), but offers the advantage of monitoring the hybridization on a microchip at different temperatures in real time for measurement of the melting curves. Melting curves are defined herein as produced by plotting the amount of duplexes [fluorescent intensity] versus temperature. The procedure, the software, and the hybridization microchamber (Yershov et al . , 1996) have all been developed for recording melting curves at a wide range of temperatures simultaneously for perfect and mismatched duplexes formed upon hybridization of a probe with all microchip oligonucleotides.
A significant amount of time is needed for the microchips hybridized with rather long RNA or DNA probes to achieve equilibrium. Therefore, non- equilibrium dissociation melting curves were measured. However, they are not far away from equilibrium where some difference in heating rate did not significantly affect the results. The melting curves for hybridization of, for example, synthetic 19-mers with the microchip oligonucleotides reached equilibrium under the same conditions that were used for measuring non- equilibrium RNA and DNA melting curves. The melting curves can also be measured after a few minutes, far away from equilibrium, if an internal standard is added to a tested sample. This standard can be a differently labeled RNA of a normal allele. This significantly speeds up the identification of nucleic acid base changes.
Example 4: Choice of Optimum Melting
Temperatures .
This invention embodies an improvement in the SHOM technology in which hybridizations between an array of gel-immobilized nucleotides (a microchip) and the unknown nucleotides to be tested are measured at optimal, discriminatory melting temperatures. This improvement is achieved by parallel measuring of the melting curves of the duplexes formed by hybridization on the entire oligonucleotide array, as well as by monitoring the simultaneous hybridization of two samples of nucleotides labeled with different fluorochromes, and judicious choice of proper allele- specific oligonucleotides as the immobilized probes. The fluorochromes chosen for the labeling emit light of sufficiently differing wavelengths, that both types of labels can be measured in the same reaction mixture.
The greatest discrimination between perfect and mismatched duplexes was achieved at a temperature at which the intensity of the hybridization signal from a perfect duplex dropped to one-tenth of its initial value; at such a temperature, the hybridization intensities from mismatched duplexes usually approached the background level . The temperature at which the initial signal of hybridization drops by a factor of 10 is termed the discrimination temperature (Td.).
In the case of beta-thalassemia mutation detections described in Example 6 herein: (1) RNA transcripts of PCR-amplified DNA were hybridized with immobilized oligonucleotides; (2) the Td values for perfect 40% and 70% GC-rich duplexes were 52° and 64°, respectively; (curves 1 and 3 in FIGS. 1A and IB); (3) the immobilized oligonucleotides were chosen from among a set of overlapping sequences; and (4) the two samples included in the reaction mixture were a mutated allele RNA labeled with one fluorochrome and a sample of the normal allele RNA labeled with a different fluorochrome .
The Td is determined by hybridization with an RNA sample if an allelic DNA is available. If such DNA is unavailable, the Td can be measured from the hybridization data resulting from experiments performed with synthetic oligonucleotides corresponding to the mutated allele of interest.
The dissociation curves for perfect and mismatched duplexes are parallel at the range of about 10° (in the middle of the curves) when plotted on a semilogarithmic scale. At this 10°C range, the ratios of the signals for perfect and mismatched duplexes remain rather constant. This makes the discrimination procedure robust to some inaccuracies in determining Td. The discrimination temperature depends on experimental conditions (rate of heating, ionic strength, probe concentration, extent of fragmentation, and so forth) which can vary from one experiment to another. However, these variations affect Td and the relative intensities of the hybridization signals to a similar extend for all microchip elements and therefore do not significantly distort the discriminations. Therefore, to provide a reference Td, the oligonucleotides CD26 (N) and CD 26 G/A, which form perfect and mismatched duplexes, respectively, with all RNAs tested, were introduced into the microchip.
Since Td is robust to some inaccuracy in measurements, 19-mer oligodeoxynucleotides were used in these experiments instead of more expensive 19-mer oligoribonucleotides . There are differences in the stability of DNA-DNA homoduplexes relative to DNA-RNA heteroduplexes (Lesnik and Freier, 1995) . The pattern of hybridization of the microchip with RNA derived from patients and with 19-mers was rather similar to that from the 10-mers. Hybridization with corresponding synthetic oligonucleotides is preferred as a control when a mutation is identified in an RNA sample by its hybridization with a diagnostic microchip.
A mixture of fluorescently labeled RNA samples was prepared from two patients; the first sample was TMP- labeled RNA from a patient that is homozygous for the normal CD26 area of the beta-globin allele; the second sample is fluorescein-labeled RNA from a patient that is heterozygous for the normal CD26 area and a mutation CD26 G/A alleles. This mixture was hybridized with a microchip consisting of two microchip elements that contained the following immobilized oligonucleotides :
SEQUENCE A sample (element) -CD26 (N-normal) 5 ' -GGCCTCACCA-3MΘU-3 ' (SEQ ID: ) B sample (element) -CD26 (G/A-mutant) 5 ' -GGCCTTACCA-3MθU-3 ' (SEQ ID:5)
The underlined bases indicate the position of a nucleotide change between the two samples.
Usage of different filters during the registration of the signal, allowed the independent, simultaneous registration of the sample, which was marked with the different dyes; TMP (red) and fluorescein (green) , on the same element of the microchip. FIG. 2 demonstrates the interaction of sample 1 with the A microchip element; Graph 2 demonstrates the interaction of sample 2 with the A microchip element; Graph 3 demonstrates the interaction of sample 2 with the B microchip element; and Graph 4 demonstrates the interaction of sample 1 interaction with the B microchip element.
Example 5 : Use of a Customized Microchip
Matrix Biosensor to Identify Nitrifying Microorganisms.
Microorganisms that degrade nitroaromatic compounds include Pseudonomas, Arthrobacter, Nocarida, Myco-bacterium, and fungi.
Previously, methods for detection of these bacteria were tedious and inaccurate. For example, to detect Pseudonomas capable of degrading nitroaromatic compounds, 2-nitroluene was tested as a sole carbon, energy and nitrogen source. It was difficult to isolate the bacteria from soil samples to perform the test .
Nitrifying bacteria have proved particularly difficult to study using cultivation techniques, such as most probable number (MPN) and selective plating because of their long generation times and poor counting efficiencies. .Thus, a rapid and non-culture dependent enumeration technique for nitrifiers could greatly facilitate research in their ecology.
Microchips with 100x100x20 μm gel pads (alternatively 60x60x20 μm) , fixed on a glass surface and containing a set of 10 oligonucleotides 15-20 bases-long were manufactured for bacterial typing experiments. The set included oligonucleotides complementary to different regions of 16S ribosomal RNA. Since rRNA's are naturally amplified, and often are present in thousands of copies per cell, they provide great sensitivity and eliminate the need for amplification in many applications. One oligonucleotide is represented in most living organisms, another is typical for most of bacteria and the rest belong to nitrosos (nitrifying) bacteria only. The group of nitrosos bacteria oligonucleotides consists of two oligonucleotides typical of nitrobacter, two typical of nitrosomonas and one typical of nitrosovibrio. One oligonucleotide was complementary to an antisense strand of rDNA for hybridization with ribosomal dsDNA, that was PCR amplified from genomic or cDNA.
The following scheme for an ordered oligonucleotide loading (placing on a chip) is useful for bacterial (or organism, species) typing. In the micromatrix design shown in Table 1, the first oligonucleotides characterize the highest order (i.e. to distinguish a living organism) . [Uni 1390-CIII] . Reducing the order step by step down to the lowest level, i.e. from family, to genus, to species provides further discrimination of oligonucleotides that are present in a sample being investigated. For example, for oligonucleotides used to classify nitrifying bacteria, a bacterial oligonucleotide would be in the next position. [Bac 338 - CI and NonBac338 - CII] . Oligonucleotides specific to nitrobacter [NblOOO - Al and NIT3 - All] and ammonia oxidizers [NEU23 - AIII, Nsol90 - AIV and Nsol225 - BI] follow in any order. Finally, oligonucleotides specific to Nitrosomonas [Nsml56 - BII] and Nitrosovibrio [Nsv443 - Bill] complete the micromatrix design.
The microchip was evaluated using three different rRNA preparations (phenol extracts of cellular RNA, RNA isolated from purified ribosomes, and in vi tro transcripts of cloned ribosomal DNA), and both fragmented double-stranded and single-stranded DNA. Hybridizations were performed in a formamide buffer at low temperature in order to enhance microchip durability and decrease RNA degradation. Although all DNA and RNA preparations could be used, the best discrimination was observed for in vi tro transcribed rRNAs using the hybridization conditions evaluated in this study.
The hybridization of the microbial microchips was carried out with five different preparations of target nucleic acids. Ribosomal RNA and total RNA were recovered from cells. RNA transcribed in vi tro as well as single- and double-stranded PCR-amplified 16S rDNA were obtained from plasmids containing the cloned 16S rRNA gene. All of these sample types provided a comparatively reliable identification of the microorganisms by their hybridization with the microchip- immobilized oligonucleotides and could be used for different purposes. For example, the rRNA provides a naturally amplified target. Also, since cellular ribosome content is well known to vary with growth rate, it is generally thought that direct quantification of rRNA serves to identify the more active environmental populations. In contrast, analysis of PCR amplified rDNA provides a more general measure of all microorganisms present in a sample.
Alternatively, these measures could be combined. For example, the RNA and DNA components of an environmental sample could be isolated and labelled with different fluorescent dyes. Following their combined hybridization, the resulting ratio of RNA and DNA hybridizing to an individual gel element could be used to infer the physiological status of the corresponding microbial population.
Table 2 shows the sequences of the oligonucleotides and other characteristics of them.
TABLE 1
Micromatrix Design for Nitrifying
Microorganisms .
Figure imgf000029_0002
Figure imgf000029_0001
TABLE 2
Figure imgf000030_0001
1 Experimentally determined.
2 Estimated from in si tu hybridization.
A number of hybridization conditions were tested in terms of efficiency and specificity of hybridization. Hybridization in formamide containing buffer at low temperature gave good results.
Hybridizations were performed at 5° centigrade in 33% formamide. RNA samples and covalent bonding of oligonucleotides with the support (hence durability of microchips) are more stable at low temperatures. In addition, these conditions were favorable from a point of view of RNA stability and microchip durability similar to other RNA molecules at low temperatures of about 0°-5°C. The hybridization on a microbial microchip was carried out with in vi tro RNA transcripts of 16S rDNA of different nitroso bacteria, total RNA extracts and ribosomal RNA extracted form E. coli and Desulfovibria vulgurus as well as PCR amplified double or single stranded DNA of 16S rDNA.
The probes for ammonia oxidizing bacteria show different discrimination specificity under different conditions. FIG. 3 shows the fluorescence of individual gel elements on the microchip following hybridization to the 16S rRNAs of Ni trosovibrio tenuis (A), Ni trosomonas europaea (B) , and E. coli , either in vi tro transcribed (C) or recovered from isolated ribosomes (D) . The same microchip was used for each hybridization following washing with distilled water. Each microchip was routinely used for up to 20-30 hybridization experiments. The appropriate pattern of hybridization was observed for all gel elements shown, despite a significant difference in dissociation temperatures (Tds) previously determined using membrane support hybridization (Table 1) . For hybrids of comparable stability, discrimination is generally achieved by washing at increasing temperatures (described below) or by simultaneously evaluating their melting characteristics, since the fluorescence analyzer can monitor hybridization signals in real time.
FIGURE 4A and 4B shows the results of an experiment evaluating the effect of increasing washing temperature on target RNA retention. A mixture of Ni trosovibrio tenuis and E. coli 16S rRNA labelled with different fluorescent dyes (fluorescein and tetramethylrhodamine, respectively) was hybridized to the chip at 5°C. The hybridization solution was then replaced with washing buffer and the retention of each RNA species was measured following each 10°C incremental increase in temperature (up to 60°C) using multicolor detection. Nonspecific hybridization of E. coli rRNA to Nsol225 (ammonia oxidizer) , Nsml56 (nitrosomonas) , and NonBac338 (anti-sense) was observed following the 10°C wash. However, this nonspecific hybridization was significantly reduced following the 40°C wash. In like manner, the 16S rRNA of Ni trosovibrio tenuis hybridized to Ni trosomonas (Nsml56) at 10°C, but was reduced to near background (compared to NonBac338) following the 40°C wash. A more complete correction for differences in stabilities of duplexes can be carried out by measuring the equilibrium or non-equilibrium melting curves for all microchip elements. This would provide a basis to compensate for the various factors influencing individual duplex stability, e.g., their length, GC-content, and competition with secondary and tertiary structures in RNA and DNA. FIG. 4B shows the ratios of hybridization intensities of fluorescein labelled Ni trosovibrio tenuis to tetramethylrhodamine labelled E. coli . with different microchip oligonucleotides at 10°C and 40°C (the ratios are derived from the data presented on Figure 4A. These ratios were not changed significantly for oligonucleotides specific to bacteria and all living organisms between 10°C and for more stringent conditions at 40°C. However, the ratio is dramatically increased at 40°C (compared to 10°C) for oligonucleotides specific to ammonia oxidizers and nitrosovibrio. This increase reflects the greater duplex stability of Ni trosovibrio tenuis RNA with the complementary oligonucleotides compared with E. coli . RNA. Although the nitrosomonas ratio increases, the signal originating from each labelled RNA is near background. This experiment demonstrates that the inclusion of second dye-labelled RNA, either isolated from cells or synthesized, could be used as an internal standard for quantitative assessments of hybridization patterns.
Variable hybridization to the different gel elements is the expected consequence of using a single hybridization condition to evaluate an array of probes, each having different kinetics of association and dissociation. To some extent these difference can be normalized by varying the concentration of oligonucleotides in the individual gel elements. For example, the relatively low hybridization signals of Nsol225(b-I) and Unil390 (c-III) compared to Nsv443
(b-III) could each be elevated by increasing the amount of the corresponding oligonucleotides probes immobilized in the gel . This approach was evaluated by synthesizing a microchip with selected probes immobilized at several different concentrations, up to 6 times higher than that used in the experiments previously described. This was accomplished by multiple applications of the standard loading solution (100 pmol/μl probe) to each gel element. Comparable hybridization of Nsol225 (ammonia oxidizer) and Nsv443 (nitrosovibrio-like) was achieved following three applications of the Nsol225 probe (FIG. 5) . Similarly, two applications of Bac338 (bacteria) and five of Unil390 (all life) resulted in hybridization comparable to Nsv443.
Strains used. Escherichia coli , Desulfovibrio vulgaris strain PT2 , Ni trosovibrio tenuis strain NV12,
Ni trosomonas europaea strain ATCC 19718, and Ni trosomonas strain C-56 were used as sources of nucleic acid for these experiments.
RNA preparation. Total cellular RNA was isolated by phenol/chloroform extraction. For some of the samples, a ribosome enrichment was performed before RNA extraction. Forty ml of log phase growth E. coli or D . vulgaris strain PT2 was centrifuged at 3500 g for 10 min. and resuspended in 4 ml of 42C ribosome buffer. Ribosome enrichment buffer consisted of 20 mM MgCl2, 50 mM KCl , 50 mM Tris at pH 7.5, and 5 mM β-mercaptoethanol in diethyl pyrocarbonate treated double-distilled water. The cell suspension was divided between 4 screwtop microfuge tubes and 0.5 g of 0.1 mm Zr02 beads were added. The cell suspensions were disrupted for 2 min., put on ice for 5 min. , and disrupted again for 2 min. The cell suspensions were centrifuged at 14000 g for 10 minutes. The supernatant, which contained the ribosomes, was recovered and transferred to ultracentrifuge tubes. Ribosomes were pelleted by ultracentrifugation in ribosome buffer at 55,000 rpm (201,000 g average) for 50 minutes in a Beckman Optima Series TL swinging bucket rotor (Beckman, Fullerton, CA) , for a Svedberg sedimentation factor of 70S. After centrifugation, the supernatant was discarded and the RNA was recovered from the pelleted ribosomes by extraction with pH 5.1 phenol/ chloroform. Quality and quantity of extracted RNA was evaluated by polyacrylamide gel electrophoresis and ethidium bromide staining.
Cloning of 16S rDNA and in vi tro production of
RNA transcripts. DNA was extracted from E. coli , Desulfovibrio vulgaris PT2 , Ni trosovibrio tenuis NV12,
Ni trosomonas europaea 19718, and Ni trosomonas strain C-56 cell pastes using a guanidine/diatom method. Near- complete 16S rDNA genes (ca. 1500 base pairs) were recovered from each by PCR amplification using S-D-Bact- 0011-a-S-17 (GTTTGATCCTGGCTCAG (SEQ ID:16)) and S-D-Bact- 1492-a-A- 21 (ACGGYTACCTTGTTACGACTT (SEQ ID:17)) as primers and a premixed PCR amplification buffer (Pharmacia Biotech Inc. Piscataway, NJ) , consisting of 0.2 mM Mg++, 2.5 mM each dATP, dCTP, dGTP, dTTP, 0.2 mM of each amplification primer, and 2.5 units of Taq DNA polymerase (Pharmacia) . Temperature cycling was done in an Idaho Technology thermocycler (Idaho Falls, ID) using 30 cycles of 15 sec at 94°C, 20 sec at 50°C, and 30 sec at 72 °C. The PCR-products were cloned in a pCR plasmid (Invitrogen, San Diego, CA) according to manufacturers instructions. Plasmids were isolated using the Wizard kit (Promega, Madison, WI) and used for in vi tro transcription of the cloned SSU rRNA genes.
DNA oligonucleotide probes. All probes were complementary to the SSU rRNAs and previously characterized using a membrane hybridization format. Five probes hybridize to different groups of ammonia-oxidizing bacteria within the beta-subdivision of the Proteojbacteria. S-G-Nso-190-b-A-19 (Nsol90) and S-G-Nso- 1225-a-A-20 (Nsol225) encompass all sequenced ammonia- oxidizers of the beta-subclass of Proteobacteria , probe
S-G-Nsm-156-a-A-19 (Nsml56) identifies members of the genus Ni trosomonas (also including Ni trosococcus mobilis) , probe S-G-Nsv-443-a-A-20 (Nsv443) is specific for the Ni trosovibrio/Ni trosolobus/Ni trosospira group, and probe S-G-Nsm-653-a-A-18 (NEU23) is specific for the halotolerant members of Ni trosomonas . Probes for members of genus Ni trobacter (nitrite oxidizing) were S-G-Nit-
1000-b-A-15 (NblOOO) and S-G-Nit-1035-a-A-18 (NIT3) . Other probes used were S-D-Bact-0338-a-A-18 (Bac338) which hybridizes to members of the bacterial domain; S-D- NBac-0338-a-S-18 (NonBac338) , complementary to the antisense strand of the Bac338, and S-*-Univ-1390-a-A-18 (Unil390) complementary to the SSU RNA of nearly all characterized living organisms, with the exception of some protists.
RNA and DNA labeling and fragmentation. Single stranded DNA was prepared by asymmetric PCR according to Ausubel et al . (1994) using a 100 times excess of the forward primer. Briefly, DNA was partially depurinated in 80% formic acid for 30 min. at 20°C, then incubated in 0.5 M ethylenediamine hydrochloride (pH 7.4) for 3 hr at 37°C, followed by 30 min. at 37°C in the presence of 0.1 M NaBH4. Fluorescein isothiocyanate was incorporated into fragmented DNA by incubation in absolute DMSO at room temperature for 1 hr.
RNA was fragmented by base hydrolysis and dephosphorylated with bovine phosphatase. Fragmented RNA was oxidized by NaI04 and labeled either by ethylenediamine mediated coupling of 6-carboxyfluorescein (FAM) succinamide or by direct incorporation of tetramethylrhodamine-hydrazide (TMR) . Microchip fabrication. A matrix of glass- immobilized gel elements measuring 60 x 60 x 20 or 100 x 100 x 20 μm each and spaced apart by 120 or 200 μm respectively was prepared. The polyacrylamide gel was activated by substitution of some amide groups with hydrazide groups by hydrazine-hydrate treatment. Oligonucleotides were activated by oxidizing 3'-terminal 3 -methyluridine using NaI04 to produce dialdehyde groups for coupling with hydrazide groups of the gel and coupled to each micromatrix element by applying 0.5-1 nl of the activated oligonucleotide solution (100 pmol/μl) using a specially devised robot.
Hybridization and image analysis. Probe binding was quantified by measuring the fluorescence conferred by the binding of fluorescently labeled DNA or RNA (tetramethyl rhodamine or fluorescein) to the individual gel elements. Hybridization and washing was controlled and monitored using a Peltier thermotable (with a working range of -5.0°C to +60.0°C) mounted on the stage of a custom-made epifluorescent microscope. The microchip was hybridized at 5°C, either overnight or for 6 hr, in 2-5 μl of the hybridization buffer [33% formamide, 0.9 M NaCl, 1 mM EDTA, 1% Tween-20, and 50 mM sodium phosphate (pH 7.0)] at a concentration of DNA and RNA between 0.2-2 pmol/μl. The hybridization mixture was replaced with 5-10 μl hybridization buffer without formamide immediately prior to microscopic observation. Exposures were in the range of 0.1-10 sec depending on the signal intensity, but were typically around 1 sec.
Fluorescence was monitored either at room temperature or using a range of temperatures between 5 - 60°C.
Conditions for the coupling of micromolecules to the acrylamide gel were devised to rule out the possibility of liquid evaporation during immobilization and to ensure that covalent bonding of oligonucleotides with the gel matrix proceeds to completion. After the microvolumes of the oligonucleotide solutions have been applied to all cells of the matrix, the micromatrix gel elements were swelled by condensing water from the ambient air. Then the micromatrix surface was covered with a thin layer of an inert nonluminescent oil, and chemical coupling of the activated oligonucleotides to the activated polyacrylamide was carried out to completion.
Example 6: Use of Microchip Biosensors As
Diagnostic Assays
The microchip technology was successfully tested for identification of single base changes in genomic DNA and RNA for reliable diagnosis of human genetic diseases. A customized microchip contained oligonucleotides specific to β-thalassemia normal and abnormal β-globin genes. The hybridization with PCR- amplified DNA or RNA samples derived from genomic DNA of subjects allowed unambiguous identification of a mutation in a sample to be tested. Reliability of the identification was enhanced by using simultaneous hybridization with two samples of a normal and mutated RNA stained with different fluorescence dyes and monitoring the hybridization at different wavelengths; by simultaneously measuring the melting curve for duplexes formed on a microchip, and by using a proper set of several oligonucleotides complementary to the mutated site of the DNA.
A number of the most commonly occurring β-thalassemia mutations with β-globin gene were used in diagnostic assays with oligonucleotide microchip biosensors. These mutations were splice-site mutations for the Is", 2nd, 5th, and 6th nucleotides in the first intron (IVS I) of the β-globin gene: IVS 1/1 G/A (G/A = substitution of G for A) , IVS 1/2 T/C, IVS 1/5 G/T, IVS 1/5 G/C, IVS 1/6 T/C, and G/A substitution in the 26th codon (GAG) of the first exon (FIG. 6) , (also known as abnormal hemoglobin E) (see Diaz-Chico et al . , 1988 for terminology) .
A microchip with 100x100x20 μm gel elements (Yershov et al . , 1996) contained immobilized decadeoxyribonucleotides, that is, 10-mers that correspond to normal and mutant β-thalassemia alleles. These 10-mers discriminated mismatches less reliably than 8-mers, but were hybridized more efficiently than 8-mers. 10-mers were, therefore, preferred for this assay. Table 3 shows the sequences of the allele-specific oligonucleotides immobilized on the microchips. It was expected that mismatches within the duplexes would have a much higher destabilization effect than mismatches at the terminal positions (Khrapko et al . , 1991); therefore the mutated bases were placed inside of the immobilized oligonucleotides .
Single- and double-stranded PCR-amplified β- globin DNA fragments of different lengths and collected after a random fragmentation were tested in assays for identification of some of these mutations. However, the hybridization of RNA is preferred over DNA hybridization. RNA fragments were derived from PCR-amplified genomic DNA by transcription with T7 RNA polymerase (Lipshutz et al . ,
1995) . About 100 copies of unlabeled or fluorescently labeled RNA transcripts are synthesized per DNA molecule, providing a convenient way to prepare a sufficient amount of the hybridization probes. RNA is fragmented and one fluorescent dye molecule is introduced per fragment .
Table 3 shows the sequences of the microchip allele specific 10-mers. The oligonucleotides of microchip I are complementary to the coding strand of DNA of the β-globin gene of patients with β-thalassemia single-base mutations (G/A - substitution of A for G) in the 1st, 2nd, 5th, or 6th nucleotides of the first intron (IVS I/l, 2, 5, 6) of the β=globm gene and in the codon #-26 (CD-26) of the first exon. Oligonucleotides 1-16 of microchip II correspond to the normal and IVS 1/2 G/T allele. The mutated and corresponding normal bases are placed from the 2nd to the 9th positions of the 10-mers from their 3 '-end. The mutated bases are shown in lowercase bold letters and corresponding oligonucleotide bases in the normal allele are underscored. The oligonucleotide synthesis and the microchip manufacturing were described by Yershov et al . (1996) .
Microchip I was successively hybridized with RNA 75 and 133 nt long without fragmentation or after fragmentation (133fr, Table 5, probes 3a and 4a) and with
6 synthetic 19-mer oligodeoxyribonucleotides corre- sponding to β-thalassemia mutations. The RNA and 19-mers were labeled with TMR except for RNA probes 2a, 2b, and 6b, which were labeled with fluorescein (FI) . The melting curves (FIG. 1A-B, FIG. 2) were measured simultaneously for all microchip oligonucleotides at each hybridization. These curves provided values of hybridization intensities at the discrimination temperature, Td. R is the ratio of the hybridization signal of a mismatched duplex (Im) to the signal of the perfect duplex (Ip) estimated at Td in parallel for all microchip oligonucleotides. R = Im/Ip. d19-synthetic 19- deoxymers were complementary to allele specific 10-mers immobilized on the microchips.
Table 4 shows the effect of the position of the allelic base within 10-mers on mutation detection. Microchip II contains two sets of 10-mers corresponding to the normal and IVS 1/2 T/G alleles. The microchip was hybridized with the TMR-labeled normal allele 19-mer and to an RNA 75 nt long. T0-1 is the temperature at which the hybridization signals for a microchip duplex drops to 1/10 of its initial value at 0°C. -Δτ0-1 = T0-1 (a perfect duplex) minus Tc-1 (the corresponding mismatched duplex.) Fluorescently labeled RNA probes were prepared from a fragment of the β-globin gene from the first exon (Lawn et al . , 1980) . PCR amplification of a 1.76-kb fragment of the human β-globin gene mapped from nucleotides -47 to +1714 (Lawn et al . , 1980) was carried out with 1 μg genomic of DNA (Poncz et al . , 1982) and 50 pmol each of the forward primer: 5'- GGAGCCAGGGCTGGGCATAAAAGT-3 ' (SEQ ID:18)) (-47->-23) and the reverse primer 5 ' -ATTTTCCCAAGGTTTGAACTAGCTC-3 ' (SEQ ID:19) (+1689->+1714) . (FIG. 7) The amplification was carried out in a DNA thermal cycler (GeneAmmp PCR System 2400, Perkin Elmer Corporation) in 100 μl of a buffer containing 200 mM each of dATP, dCTP, dGTP, dTTP, 2.5 mM MgCl2, 2 units of Taq DNA polymerase (BioMaster, Russia), 50 mM KC1, 10 mM Tris-Hcl, pH 9.0, and 0.1% Triton X-100. The reaction conditions were 30 cycles, with 45 sec at 95°C, 90 sec at 66°C, and 120 sec at 72°C. PCR product was purified from 2% low gel/ melting temperature agarose gel (NuSieve agarose, FMC) . The 159 bp and 102 -bp DNA fragments were amplified with 10 ng of the 1.75 kb DNA with three nested primers, two containing T7 promoter sequence and a common reverse primer. The nested primers were T7-V2L-45.
(5 ' -GGAATTCCTAATACGACTCACTATAGGGA
CACCATGGTGCACCTGACTCC-3 ' (SEQ ID:1) -44->+66); T7-V2L-103 (5 ' -GGAATTCCTAATACGACTCACTATAGGGAGGTGAACGTGGATGAAGTTGG-3 ' (SEQ ID:2); +102 - >-123 ) ; and 5 ' -TCTCCTTAAACCTGTCTTGTAACC- 3' (SEQ ID:3) (common reverse ; 153 - >+176 ) . The amplification was carried out in 25 cycles (15 sec at 95°C, 30 sec at 62°C, and 30 sec at 72°C) . PCR products were purified by QIAGEN QIAquick PCR Purification Kit. The PCR-amplified 159 or 102 bp DNA (4-5 μg) containing T7 promoter was transcribed with 400 units of T7 RNA polymerase (Promega) to produce 133 and 75 nt long RNA in 80 μl of buffer containing 300 mM HEPES , pH 7.6 , 30 mM MgCl2, 16 μg of BSA, 40 mM DTT, 30 units of Rnasin
(Promega) and 4 mM each of ATP, CTP, GTP, and UTP for 3 h at 38°C. Deproteinization of the reaction mixture was carried out in 20 mM EGTA, pH 8.0 , 2% SDS, and Proteinase K (10 mg/ml) for 15 min at 37°C. The mixture was extracted first with equal volumes of phenol and then with equal volumes of chloroform, precipitated twice by one volume of isopropyl alcohol, from 0.5 M LiC104 and dissolved on a Bio-Spin P6 column (BioRad) .
Fragmentation of 10-100 μg of RNA to an average length of 20- to 40-mers was carried out in 50 μl of 0.1 M KOH for 30 min. at 40°C. Then 5 μl of 1M HEPES, pH 7.6, and 15 μl of 1% HC04 were added at 4°C. The pellet of potassium perchlorate was removed by centrifugation and RNA was precipitated by 10 volumes of 2% LiC104 in acetone. The RNA was washed twice with acetone and dried for 20-30 min. at room temperature. The fragmented RNA was dephosphorylated in 50 μl of 20 mM Tris-HCl, ph 8.0, 1 mM MgCl2, 1 mM ZnCl2, 10 units of Rnasin, 5-7 units of calf intestine phosphatase (CIP) for 1 hour at 37°C. RNA deproteinization and purification was carried out as described herein.
For chemical fluorescence labeling of RNA the 3 '-terminal dephosphorylated nucleoside was oxidized in 20 μl of 10 mM sodium periodate for 20 min. at room temperature. RNA was precipitated with acetone. A 10 molar excess of 10 mM TMR-hydrazine in 10% acetonitrile was added to oxidized RNA fragments in 20 μl of 20 mM sodium acetate at pH 4.0. The reaction mixture was incubated 30-40 min at 37°C, and the hydrazide bond between the RNA and dye was stabilized by reduction with freshly prepared 1.5 μl of 0.2 M NacNBH3 and incubated for 30 min. at room temperature. Then the mixture was extracted four times with water saturated n-butanol and precipitated with acetone. Alternatively, RNA was labeled by incorporation of fluorescein-UTP during the transcription with Ambion MEGAshortscript kit according to the manual. The hybridization of fluorescently labeled RNA
(1 pmol/μl) with the microchips was carried out at 0°C for 18 h. In many cases, the intensities of the hybridization signals at 0°C were similar for perfect and mismatched duplexes. The perfect and mismatched duplexes as well as the duplexes having various GC and AT contents displayed different stabilities and therefore were tested at different temperatures.
Table 4 summarizes the results of hybridization of the diagnostic microchips with 1) RNA probes derived from a number of homozygous and heterozygous β-thalassemia patients; and 2) with corresponding 19-mers. The table shows the Td for perfect duplexes formed on each microchip oligonucleotide. The relative intensities, R, of the hybridization signals for a different microchip oligonucleotides in Table 3 are normalized to the signals for a perfect duplex at the Td (estimated as 1.0) . In most cases the ratios for mismatched duplexes are less than 0.1 and close to 0. These values are low enough to allow unambiguous identification of the homozygous and heterozygous mutations in patients at the Td (when the hybridization signals from only perfect duplexes are observed) . The hybridization of homozygote RNA (Table 5, probes la, 2a, 2b, and 3a) with the microchip shows the distinctive formation of a perfect duplex only with one immobilized oligonucleotide and mismatched duplexes with all others. Two perfect duplexes were unambiguously identified upon hybridization with a heterozygote RNA (Table 5, probe 4a) .
Table 3. The sequence of the microchip allele specific 10-mers.
Figure imgf000045_0001
In Table 3, mutated oligonucleotide bases are shown m lower case and bold, and corresponding oligonucleotide bases m the corresponding normal alleles are underlined. TABLE 4
The effect of the position of the allele base within 10-mers on mutation detection.
Figure imgf000046_0001
TABLE 5
Identification of β-thalassemia mutations by hybridization with the microchip
Figure imgf000047_0001
(Table 5 continued on next page)
Figure imgf000048_0001
The noticeable exceptions are oligonucleotides corresponding to IVS V2 T/A and IVS V2 T/G mutations that show strong mismatched signals upon hybridization with non-corresponding samples of IVS (N) and IVS Vz T/A RNA's, respectively (Table 5, la, 2b, 4a, 6a and 6b) . The relative intensities of these mismatched signals can be significantly decreased by choosing the proper oligonucleotides for immobilization. It appears that the diagnostic assays can be carried out with RNAs 75 nucleotides (nt) long (Table 5, probes la, and 6a) , and 133 nt long (probes 2a and 6b) , as well as with 133 nt long RNA fragmented to pieces 20-40 nt long (probes 3a and 4a) . However, the intensities of the hybridization signals after fragmentation are increased by about 5 times and the time of hybridization is decreased from several hours to a tens of minutes .
The longer RNA probes diffuse more slowly into the gel and can form stable secondary structures or aggregates . These factors interfere with their hybridization with rather short immobilized oligonucleotides. Thus, the fragmentation seems to be an essential step in sample preparation, since it enhances and speeds the hybridization.
In addition to the measuring of the melting curves, the reliability of identification of mutations and base changes can be enhanced by the use of a multicolor fluorescence microscope (Yershov et al . ,
1996) . For this purpose, the tested RNA is marked by one fluorescence label and is hybridized with a microchip in the presence of a normal allele sample labeled with a different dye. The pattern and the ratio of hybridization measured with the two dyes will be similar for all microchip oligonucleotides except for those that correspond to different allele bases, i.e., mutations. Table 4 shows the results of such an experiment. The patterns of hybridization detected at two wavelengths are very similar.
As shown in Table 3, the immobilized 10-mers matching the mutations IVS 1-2 T/G, IVS 1-2 T/C, and IVS 1-2 T/A are hybridized rather strongly with some RNA probes that correspond to other alleles. Different structural factors in RNA could cause this hybridization. The effect of these factors can be minimized by placing a variable IVS 1-2 base into different positions of the 10-mers. The results of such experiments are shown in Table 4. Microchip II was successively hybridized with fragmented 75-nt-long RNA or with a synthetic DNA 19-mer, both corresponding to the normal allele. Microchip II contained two similar sets of eight overlapped immobilized 10-mers that are complementary either to a normal allele or to IVS 1-2 T/G allele. The allele specific bases A for the first set and C for the second set are located in these 10-mers in all internal positions from the 2nd to the 9th. These bases form perfect A-T or mismatched A-G base pairs, respectively. The stability of the perfect and mismatched duplexes formed on the microchip is determined as T0-1 the temperature at which the initial hybridization signal of the duplex is decreased to one-tenth of the original intensity. Δτ0-1 corresponds to the difference in TQ 1 between the perfect and similar mismatched duplexes. A better discrimination of the perfect and mismatched duplexes is reflected in higher values of Δτ0-1. The discrimination efficiency (ΔT) was lower for hybridized RNAs than for the 19-mers. The discrimination was surprisingly low, ΔT = -2° and 3°C, when the allelic bases were placed at the 9th or 7th position, respectively, of the immobilized oligonucleotides. It appears that secondary structures and the presence of similar sequences in other regions of the RNA causes this lowering. These effects can be partly predicted from the sequence of the region that is searched for mutations. However, it is impossible to reach a high discrimination
(ΔT =8-ll°C) when allele bases are placed in other positions, for example the 8, 6, 5, or 4 positions. The hybridization of RNA transcripts of PCR- amplified DNA with oligonucleotide microchips allows the reliable identification of base changes and discrimination of homozygous and heterozygous β-thalassemia mutations in the genomic DNA of patients. RNA transcribed from PCR-amplified DNA provides an easier method for preparing a sufficient amount of labeled, single-stranded samples than the use of DNA prepared by PCR amplification. RNA can be fragmented and one fluorescent dye molecule can be introduced per fragmen .
Example 7 : Use of a Customized Microchip Biosensor to Detect Gene Expression
Gene expression is one of the central themes in modern molecular biology. DNA from well studied genetical sources has already been systematically sequenced. For these sequences hybridization procedures are successfully used to estimate a level of differential gene expression. The results of this estimation are useful for understanding fundamental mechanisms of development biology, embryology and treatment of genetic and infectious diseases .
To determine whether oligonucleotide microchips are useful to identify gene expression, microchip biosensor hybridization was carried out with ssDNA fragments isolated from six different genes:
- 205 b fragment from glyceraldehyde 3 -phosphate dehydrogenase (G3PDH) ;
- 281 b fragment from human transferrin receptor (HTR) ; - 224 b fragment from human β2-microglobulin (B2M) ; - 545 b fragment from human interleukin-1 receptor (IL1R) ;
- 188 b fragment from human NF-kB (p50);
- 224 b fragment from human interferon γ receptor (IGR) .
A customized microchip, containing immobilized 60 b oligonucleotides, having at the 3 ' -terminal position 3-methyluridine residues, corresponding to five housekeeping genes (G3PDH, HTR, B2M, IL1R and NF-kb(p50)) (CLONTECH catalog 94/95 "Tools for the Molecular
Biologist", pp. 90-93) were produced for hybridization experiments with complementary ssDNA fragments. Each oligonucleotide was applied at two positions on the microchip in a 1:10 ratio of amount (0.3 pmol: 0.03 pmol each) . ssDNA fragments complementary to immobilized oligonucleotides were synthesized by asymmetric PCR amplification (using only one primer) with fluorescently labeled nucleotide triphosphates { FUORscript T7 ,
Fluorescein-Labeling In Vitro Transcription Kit) . Moreover, the PCR-primer bore a biotin tag that was utilized for following isolation of synthesized ssDNA fragments with avidin carried on a column (Sambrook et al. "Molecular Cloning" 2d edit., p. 12.14). FIG. 8 demonstrates hybridization on the microchip. Intensity of fluorescence in each spot depends on the amount of immobilized oligonucleotide and on the length of the DNA fragment in the spot. For hybridization, 10 μl of Buffer A (50% formamide, 10% dextran sulfate, 1% SDS, 50 mM sodium phosphate at pH 7.4, 750 mM sodium chloride, 5 mM sodium EDTA) containing ssDNA with a concentration of 0.5 pmol/μl (approximately 0.05 μg/μl) was incubated for about 6 - 12 h at room temperature, washed briefly with H20 and analyzed with a fluorescent microscope. Before rehybridization the microchip was treated in Buffer B (50% formamide, 1% Tween 20) for 30 min. at 50°C to completely remove hybridized ssDNA.
These results indicate that concentration of fluorescently labeled ssDNA may be decreased up to 100 fold. Hybridization with individual ssDNA fragments indicates high specificity of studied oligonucleotides. There was no cross-hybridization detected between different tested DNAs and immobilized oligonucleotides. None of the oligonucleotides demonstrated a signal when hybridized with non-specific DNA (e.g. probe IGR) . This differentiates "expression" of non-expressed genes from expression of housekeeping genes. Genes that are not expressed in a particular cell or tissue, may actually be picked up in conventional screening procedures as having a low expression, while other genes being expressed in all cells (housekeeping genes) will also be picked up as having low to moderate expression. The housekeeping genes are actually being expressed. In this example a difference in signal is detectable so that low level expression could be unambiguously distinguished from low level background.
The procedure detects expression of genes of high and middle expression level. To determine low level gene expression selective RT-PCR amplification is preferred. Example 8 : Use of a Customized Microchip Biosensor to Detect HLA Polymorphisms
A difficult problem of genotype recognition arises in studying different haplotypes (alleles) of genes encoding Human Leucocyte Antigens (HLA) in regions of histocompatibility genes. The HLA locus (class I and class II genes) is responsible for histocompatability of tissue transplantation. The need for allele identification is encountered also in various medical and biological tasks involving HLA class II genes. There are many clinical data showing strong association between HLA genotype and suspectibility to some disorders, for example some alleles DQAl/DQBl are clearly related to IDDM (Insulin - Dependent Diabetes Mellitus) , malaria, autoimmune diseases, such as rheumatoid arthritis and pemphigus vulgaris - a skin disease which causes severe blistering. The high level of polymorphism of HLA has been shown to be useful for identification of individuals determining the group of risk for some diseases. HLA typing is particularly crucial for matching donors for transplants. It is also proposed for infertility work- ups .
In this aspect, the present invention provides a method which allows an array of immobilized 8-12 bp- long oligonucleotides to form an oligonucleotide microchip thereby facilitating identification of HLA DQAl allies.
An algorithm has been designed and special computer programs have been constructed which allow the analysis of the nucleotide sequences of all alleles of various HLA subloci . Forming an optimized set of oligonucleotides provides high reliability of detection of homo- and heterozygotes for the HLA alleles.
A customized microchip, containing an array of eighteen PAA - gel immobilized (lpmol of each) short oligonucleotides has been produced for hybridization with fluorescently labelled complementary HLA DQAl DNA or RNA probe for allele identification. 18 decamers were loaded on the chip in the following order, from left to right:
Figure imgf000054_0001
The sequence of the oligos used was as shown in FIG. 9.
The oligonucleotides immobilized on the microchip are complementary to the sense strand of different alleles of DQAl DNA and some control oligos . A microchip with 20 oligonucleotides was manufactured for partial identification of 15 different alleles in the HLA DQAl region. PCR was used to prepare 229 bp (starting from codon 12 to codon 87) DNA fragments of the polymorphic second exon of the DQAl gene from human genomic DNA. Nested primers were used 2DQAAMP-A: 5 ' - a t ggt gta aac ttg tac cag t ; and 2DQAAMP- B:5'tt ggt age age ggt aga gtt g. Nested PCR primers were: T7-2DQAAMP-A and primer B. The first primer containing the promoter for T7 RNA polymerase and PCR product were used for in vi tro transcription. RNA probes were identical to the coding DNA strand. RNA was fragmented, labelled with fluorescein and used for hybridization with the microchip. Hybridization conditions were as follows: overnight incubation at 5°C in IM NaCl, ImM EDTA, 5 mM Na-phosphate, pH7.0 , 1% Tween 20. The temperature was then increased stepwise at 10°C intervals, and fluorescence measurements were taken at each step. FIG. 10 shows the hybridization results and presents schematically the HLA DQAl - chip for allele identification. In FIG. 10 three diagonally placed oligos (11-0101/0104 allele specific; 6-specific for 0101,01021,01022,0103,00104; 17-correspond to all alleles, except 0502) gave a positive hybridization signal, and are observed as three diagonally placed bright fluorescence spots . The probes were identified as the 0101 or 0104 allele (both alleles are identical in the second exon) . All other oligos yielded much weaker fluorescence signals compared with those described above, because none of them contain sequences complementary to alleles 0101 and 0104. On the other hand any allele different from 0101 or 0104, reveals another set of hybridization signals. The brightest fluorescent squares on the chip were:
Oligo# 4 which is 03011 or 0302 specific; oligo# 8 is Taq polymerase-specific artifacts; oligo# 18-belong to alleles 0101-05011; oligo 11-0101,0104 allele specific; 17 - corresponds to all alleles, except 0502; g4 is a fluorescent control oligo; #13 - mismatch to #18. All other chip elements showed significantly less intensive fluorescence. The genotype identified by these probes has a 0101/0104-0302/03011 heterozygote .
Example 9: Use of a Customized Microchip Biosensor to Detect the Lyme Disease Spirochetes
Bacteria belonging to the species Barretia burgdorferi and related species of tick-borne spirochetes are capable of causing human and veterinary disease.
Nucleic acid probes are available to detect bacteria causing Lyme disease. These bacteria cannot be identified by standard microbiological methods, although immunological tests are available.
Using the methods of the present invention, oligonucleotides are prepared according to eisburg (1995) and added to a micromatrix designed for use in detecting Lyme disease in a clinical sample.
Example 10: Use of a Customized Microchip Biosensor to Detect Salmonella In Food Samples
Salmonella presence is detected most commonly by preparing cultures according to standard microbiological laboratory procedures, and testing the cultures for morphological and biochemical characteristics. After about 48 hours after collection of a sample testing begins and takes several days to complete. However, RNA and DNA probes for Salmonella testing are available. Using the methods of the present invention, oligonucleotides are prepared according to Lane et al . (1996) incorporated herein by reference and added to a microchip designed for use in detecting Salmonella in food samples by distinguishing rRNA of Salmonella from non-Salmonella.
DOCUMENTS CITED
AUSUBEL, F.M., et al . (1994) Current Protocols in Molecular Biology. Greene Wiley Interscience: New York, NY.
BEATTIE, K.L., et al . (1995) Clin . Chem . 41/5
700-706.
CONNER, B.J., et al . (1983) Proc . Na tl . Acad .
Sci . USA 80: 278-282. DIAZ-CHICO, J.C., et al . (1988) J". Biochim .
Biophys . Acta 949: 43-48.
FODOR, S.P.A., et al . (1991) Sci ence 251:767-
773.
GHU, Z., et al. (1994) Nucl . Acids Res . 22:5456-5465.
KHRAPKO, K., et al . (1991) J. DNA Sequencing 1
375-388.
KHRAPKO, K. R. et al . (1996) U.S. Pat.
No. 5,552,270. LAMTURE, J.B., et al . (1994) Nucl . Acids Res .
22 :2121-2125.
LANE, D.J. et al . (1996) U.S. Pat.
No. 5,495,008.
LAWN, R. et al . (1980) Cel l 21: 647-651. LESNIK, E.A., et al . (1995) Biochemis try 34:
10807-10815.
LIPSHUTZ, R.J., et al . (1995) BioTechniques 19:
442-447.
MAIDAK, B.C. et al . (1996) Nucl . Acids Res . 24:82-85.
MATSON, R.S., et al. (1995) Anal. Biochem .
224 :110-116. MIRZABEKOV, A. (.1994) Trends in Biotechnology
12:27-32.
MOBARRY, B.K. et al. (1996) Appl. Environ.
Microbiol. 62:2156-2162. PEASE, A.C., et al. (1994 J Proc. Natl. Acad.
Sci. USA 91:5022-5026.
PONCZ, M. et al. (1982) Hemoglobin 6:27-40.
STAHL, D.A. (1995) Mol . Ecol . 4:535-542.
SOUTHERN, E. M. (1996) TIG 12:110-115. SOUTHERN, E.M., et al . (1992) Genomics 13:1008-
1017.
WAGNER, M. et al . (1995) Appl. Microbiol
18 =251-264.
WEISBURG, W.G. (1995) U.S. Pat. No. 5,466,577. WOESE, C.R. (1987) Microbial. Rev. 51:221-271.
YERSHOV, G., et al . (1996) Proc. Natl. Acad.
Sci. USA 93:4913-4918.
U.S. Pat. No. 5,552,270

Claims

WE CLAIM ;
1. A method for using a microchip to identify a nitrogen base sequence in a nucleic acid of a sample, said method comprising: a) extracting the nucleic acid from said sample ; b) providing a customized matrix of oligonucleotides having a sequence identity on the microchip designed to identify the nitrogen base sequence of an oligonucleotide in the sample; c) hybridizing said extracted nucleic acid on said microchip; and d) identifying the nitrogen base sequence in said sample by comparing the sequence identity of the microchip oligonucleotides which hybridized to the sample nucleic acid and the sequence identity of the microchip oligonucleotides which did not hybridize.
2. The method of claim 1, wherein said nitrogen base sequence is in a DNA molecule .
3. The method of claim 1, wherein said nitrogen base sequence is in a 16S RNA, mRNA or other RNA molecule.
4. The method of claim 1, wherein the customized matrix of oligonucleotides affixed to a support is formed by a plurality of gel elements, the number of elements is determined by the number of oligonucleotides in the matrix; and wherein each gel element contains one oligonucleotide of a desired nitrogen base sequence length and concentration; said gel elements being separated from one another by hydrophobic glass spaces; and wherein the gel elements have a vertical height above the plane of the interstitial spaces of not more than about 30 ╬╝m .
5. The method of claim 4, wherein said oligonucleotide matrix comprises oligonucleotides having the base sequences
Figure imgf000061_0001
6. The method of claim 5, wherein the oligonucleotides are arranged in the matrix
Figure imgf000061_0002
The method of claim 1, wherein the sample is water.
The method of claim 1, wherein the sample is blood.
9. The method of claim 1, wherein the sample is a food.
10. The method of claim 1, further comprising: e) adding a label to the nitrogen base sequence in said sample before bringing it in contact with the array.
11. The method of claim 10, wherein the label is a fluorescent dye.
12. The method of claim 10, wherein the label is a plurality of different dyes.
13. The method of claim 1, wherein the oligonucleotides on the microchip are complementary to the beta globin gene .
14. The method of claim 1, wherein the oligonucleotides on the microchip are complementary to a sequence specific for Salmonella.
15. A microchip matrix for the detection and classification of nitrifying bacteria wherein said matrix has the following design:
Figure imgf000063_0001
and wherein the base sequences are
Figure imgf000063_0002
16. A diagnostic assay for the presence of a mutation in a gene said assay comprising: a. designing a customized microchip biosensor comprising an oligonucleotide that hybridizes to the gene having the mutation; b. contacting an assay sample to the customized microchip biosensor under conditions that allow hybridization of the gene to the microchip; and c. determining whether hybridization occurs from which presence of the mutation in the gene is determined.
17. A method for detecting mismatches between a nitrogen base sequence on a microchip and a nitrogen base sequence to be tested, said method comprising: (a) simultaneously monitoring hybridization between the nitrogen base sequence on the microchip and the nitrogen base sequence to be tested at a series of temperatures ;
(b) selecting the temperature at which maximum hybridization occur; and
(c) determining the degree of mismatch from the selected temperature .
18. The method of claim 17, wherein the selected temperature is that temperature at which the intensity of a predetermined hybridization temperature from a perfectly matched duplex is one tenth of its initial value .
19. A customized oligonucleotide microchip for the detection of a betaglobin, mutation, said microchip containing space oligonucleotides have the following nitrogen base sequences with identifiers:
IVS (N) 5' -TMR-CCTGGGCAGGTTGGTATCA-3 ' (SEQ ID:48)
IVS 1/2 T/A 5' -TMR-CCTGGGCAGGaTGGTATCA-3 ' (SEQ ID:49)
IVS /1 G/A 5 ' -T R-CCTGGGCAGaTTGGTATCA-3 ' (SEQ ID:50)
IVS 1/6 T/C 5 ' -TMR-CCTGGGCAGGTTGtTATCA-3 ' (SEQ ID:51)
IVS 1/5 G/T 5' -TMR-CCTGGGCAGGTTGtTATCA-3 ' (SEQ ID:52) CD26 (N) 5' -TMR-GTTGGTGGTGAGGCCCTGG-3 ' (SEQ ID: 53)
CD26 G/A 5' -TMR-GTTGGTGGTaAGGCCCTGG-3 ' (SEQ ID:54).
20. A customized oligonucleotide microchip for quantitation of the expression of a gene.
21. A customized oligonucleotide microchip for the detection of HLA polymorphism.
22. The customized oligonucleotide microchip of claim 21 comprising the following oligonucleotides:
-AGGCAACGTG (SEQ ID: 55)
-AGGCGACGTG (SEQ ID: 56)
-GGTGAACTGG (SEQ ID: 57)
-TAAATCTGCG (SEQ ID: 58)
-AGGCAACATG (SEQ ID: 59)
-CAAAACCTCC (SEQ ID: 60)
-GCAAACACCA (SEQ ID: 61)
-TACACCATAA (SEQ ID: 62)
-ACTGCTCATC (SEQ ID: 63)
-CAATGTCTTC (SEQ ID: 64)
-CTCCTCATCT (SEQ ID: 65)
-TGCCGGTCAA (SEQ ID: 66)
-TTAGGACAGC (SEQ ID: 67)
-ACACCACAAG (SEQ ID: 68)
-CACAATGCCT (SEQ ID: 69)
-CAGCAGTAGA (SEQ ID: 70)
-TGCGGGTCAA (SEQ ID: 71)
-TTAGCACAGC (SEQ ID: 72) .
PCT/US1997/023778 1996-12-23 1997-12-19 Customized oligonucleotide microchips as multiple biosensors WO1998028444A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97953408A EP0951569A2 (en) 1996-12-23 1997-12-19 Customized oligonucleotide microchips as multiple biosensors
AU57160/98A AU5716098A (en) 1996-12-23 1997-12-19 Customized oligonucleotide microchips as multiple biosensors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78002696A 1996-12-23 1996-12-23
US08/780,026 1996-12-23

Publications (2)

Publication Number Publication Date
WO1998028444A2 true WO1998028444A2 (en) 1998-07-02
WO1998028444A3 WO1998028444A3 (en) 1998-12-17

Family

ID=25118334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/023778 WO1998028444A2 (en) 1996-12-23 1997-12-19 Customized oligonucleotide microchips as multiple biosensors

Country Status (3)

Country Link
EP (1) EP0951569A2 (en)
AU (1) AU5716098A (en)
WO (1) WO1998028444A2 (en)

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052208A2 (en) * 1999-03-03 2000-09-08 The University Of Chicago Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
WO2000066789A2 (en) * 1999-05-03 2000-11-09 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
WO2001036683A2 (en) * 1999-11-16 2001-05-25 Apollo Biotechnology, Inc. Method for rapid and accurate identification of microorganisms
US6238870B1 (en) 1993-12-10 2001-05-29 California Institute Of Technology Nucleic acid mediated electron transfer
EP1132485A2 (en) * 2000-03-10 2001-09-12 Hitachi Software Engineering Co., Ltd. Method and device for detecting hybridization reaction
US6291188B1 (en) 1995-06-07 2001-09-18 California Institute Of Technology Metallic solid supports modified with nucleic acids
EP1136566A1 (en) * 2000-03-24 2001-09-26 Facultés Universitaires Notre-Dame de la Paix Method and kit for detection and/or quantification of homologus nucleotide sequences on arrays
WO2001077372A2 (en) * 2000-03-24 2001-10-18 Facultes Universitaires Notre-Dame De La Paix Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US6342359B1 (en) * 1999-10-01 2002-01-29 Lg Electronics Inc. Method for detecting nucleic acids, detector for nucleic acids and method for producing the same
FR2815043A1 (en) * 2000-10-05 2002-04-12 Skuld Tech RAPID METHOD OF DETECTION OF ORGANISMS IN A SAMPLE
US6391937B1 (en) 1998-11-25 2002-05-21 Motorola, Inc. Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers
WO2002040711A1 (en) * 2000-11-17 2002-05-23 Biomerieux S.A. Method for analysing a patient's predisposition to insulin-dependent diabetes, device and set of primers
EP1242631A1 (en) * 1999-12-15 2002-09-25 Conagra Grocery Products Companies Multispecies food testing and characterization
US6479240B1 (en) 1996-11-05 2002-11-12 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US6528266B2 (en) 1993-12-10 2003-03-04 California Institute Of Technology Nucleic acid mediated electron transfer
US6541617B1 (en) 1998-10-27 2003-04-01 Clinical Micro Sensors, Inc. Detection of target analytes using particles and electrodes
FR2833969A1 (en) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Biochip that carries high purity molecular probes, useful e.g. for diagnosis, specifically of breast cancer, and for analysis of DNA repair
FR2833968A1 (en) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Thematic biochip, useful e.g. for diagnosis, particularly of breast cancer, and treatment selection, comprises thematic probes and probes for interpretation
US6686150B1 (en) 1998-01-27 2004-02-03 Clinical Micro Sensors, Inc. Amplification of nucleic acids with electronic detection
US6761816B1 (en) 1998-06-23 2004-07-13 Clinical Micro Systems, Inc. Printed circuit boards with monolayers and capture ligands
EP1469067A1 (en) * 2002-01-25 2004-10-20 Olympus Corporation Method and apparatus for detecting nucleic acid data
EP1524320A1 (en) * 2003-10-15 2005-04-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Rapid determination and quantification of mycoplasma contamination using DNA chip technology
WO2005047012A1 (en) 2003-11-07 2005-05-26 De La Rue International Limited Security device
US6960298B2 (en) 2001-12-10 2005-11-01 Nanogen, Inc. Mesoporous permeation layers for use on active electronic matrix devices
US7045285B1 (en) 1996-11-05 2006-05-16 Clinical Micro Sensors, Inc. Electronic transfer moieties attached to peptide nucleic acids
US7160678B1 (en) 1996-11-05 2007-01-09 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
EP1762628A1 (en) 2005-09-13 2007-03-14 Eppendorf Array Technologies SA Detection method of homologous sequences differing by one base on a microarray
US7202026B2 (en) 2000-03-24 2007-04-10 Eppendorf Array Technologies Sa (Eat) Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array
US7267939B2 (en) 1997-06-12 2007-09-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US7338763B2 (en) 2004-06-02 2008-03-04 Eppendorf Array Technologies S.A. Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
EP1925678A1 (en) * 1999-05-03 2008-05-28 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
US7393645B2 (en) 1996-11-05 2008-07-01 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
EP1981985A1 (en) * 2006-01-05 2008-10-22 Simons Haplomics Limited Microarray methods
US7449328B2 (en) 1999-05-03 2008-11-11 Gen-Probe Incorporated Probe matrix-based device for identifying microorganisms
US7829313B2 (en) 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7875442B2 (en) 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
EP2277032A1 (en) * 2008-05-09 2011-01-26 Zhiping Liu A molecule detecting system
US7935481B1 (en) 1999-07-26 2011-05-03 Osmetech Technology Inc. Sequence determination of nucleic acids using electronic detection
EP1812594B1 (en) * 2004-11-18 2013-01-09 Eppendorf Array Technologies Real-time quantification of multiple targets on a micro-array
US8486247B2 (en) 1999-04-21 2013-07-16 Osmetch Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
WO2017100454A1 (en) 2015-12-09 2017-06-15 Intuitive Biosciences, Inc. Automated silver enhancement system
US9874542B2 (en) 1998-09-17 2018-01-23 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011548A1 (en) * 1988-05-20 1989-11-30 Cetus Corporation Immobilized sequence-specific probes
WO1990015157A1 (en) * 1989-05-31 1990-12-13 Gene-Trak Systems Universal eubacteria nucleic acid probes and methods
WO1995000530A1 (en) * 1993-06-25 1995-01-05 Affymax Technologies N.V. Hybridization and sequencing of nucleic acids
US5462855A (en) * 1990-05-09 1995-10-31 Bayer Aktiengesellschaft Method for the detection and quantitative determination of nitrosomonas strains in wastewaters or soils
WO1996008582A2 (en) * 1994-09-12 1996-03-21 Bergeron Michel G Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5552270A (en) * 1991-03-18 1996-09-03 Institut Molekulyarnoi Biologii Imeni V.A. Methods of DNA sequencing by hybridization based on optimizing concentration of matrix-bound oligonucleotide and device for carrying out same
WO1996036733A1 (en) * 1995-05-19 1996-11-21 Akzo Nobel N.V. Nucleic acid primers for amplification of a mycobacteria rna template

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011548A1 (en) * 1988-05-20 1989-11-30 Cetus Corporation Immobilized sequence-specific probes
WO1990015157A1 (en) * 1989-05-31 1990-12-13 Gene-Trak Systems Universal eubacteria nucleic acid probes and methods
US5462855A (en) * 1990-05-09 1995-10-31 Bayer Aktiengesellschaft Method for the detection and quantitative determination of nitrosomonas strains in wastewaters or soils
US5552270A (en) * 1991-03-18 1996-09-03 Institut Molekulyarnoi Biologii Imeni V.A. Methods of DNA sequencing by hybridization based on optimizing concentration of matrix-bound oligonucleotide and device for carrying out same
WO1995000530A1 (en) * 1993-06-25 1995-01-05 Affymax Technologies N.V. Hybridization and sequencing of nucleic acids
WO1996008582A2 (en) * 1994-09-12 1996-03-21 Bergeron Michel G Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
WO1996036733A1 (en) * 1995-05-19 1996-11-21 Akzo Nobel N.V. Nucleic acid primers for amplification of a mycobacteria rna template

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BORMAN S: "DNA CHIPS COME OF AGE AFTER PERIOD OF GESTATION, TECHNOLOGY FOR GENETIC ANALYSIS IS BLOSSOMING" CHEMICAL AND ENGINEERING NEWS, vol. 74, no. 50, 9 December 1996, page 42/43 XP000633458 *
CHEE M ET AL: "ACCESSING GENETIC INFORMATION WITH HIGH-DENSITY DNA ARRAYS" SCIENCE, vol. 274, 25 October 1996, pages 610-614, XP002022508 *
DROBYSHEV ET AL.: "SEQUENCE ANALYSIS BY HYBRIDIZATION WITH OLIGONUCLEOTIDE MICROCHIP: IDENTIFICATION OF BETA-THALASSEMIA MUTATIONS" GENE, vol. 188, no. 1, March 1997, pages 45-52, XP002064990 *
ERLICH, HENRY A. ET AL: "HLA DNA typing" , PCR PROTOC.: GUIDE METHODS APPL. (1990), 259-71. EDITOR(S): INNIS, MICHAEL A. PUBLISHER: ACADEMIC, SAN DIEGO, CALIF. CODEN: 56TMAY XP002079984 see page 267 *
GUSCHIN ET AL.: "OLIGONUCLEOTIDE MICROCHIPS AS GENOSENSORS FOR DETERMINATIVE AND ENVIROMENTAL STUDIES IN MICROBIOLOGY" APPLIED AND ENVIROMENTAL MICROBIOLOGY, vol. 63, no. 6, June 1997, pages 2397-2402, XP002064989 *
MIRZABEKOV ET AL.: "DNA SEQUENCING BY HYBRIDIZTION- A MEGASEQUENCING METHOD AND A DIAGNOSTIC TOOL?" TIBTECH, vol. 1994, no. 12, 1994, pages 27-32, XP002064988 cited in the application *
SHALON D ET AL: "A DNA MICROARRAY SYSTEM FOR ANALYZING COMPLEX DNA SAMPLES USING TWO-COLOR FLUORESCENT PROBE HYBRIDIZATION" GENOME RESEARCH, vol. 6, no. 7, 1 July 1996, pages 639-645, XP000597095 *
YERSHOV ET AL.: "DNA ANALYSIS AND DIAGNOSTICS ON OLIGONUCLEOTIDE MICROCHIPS" PNAS, vol. 93, May 1996, pages 4913-4918, XP002064987 cited in the application *

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238870B1 (en) 1993-12-10 2001-05-29 California Institute Of Technology Nucleic acid mediated electron transfer
US6528266B2 (en) 1993-12-10 2003-03-04 California Institute Of Technology Nucleic acid mediated electron transfer
US7033760B2 (en) 1995-06-07 2006-04-25 California Institute Of Technology Metallic solid supports modified with nucleic acids
US6291188B1 (en) 1995-06-07 2001-09-18 California Institute Of Technology Metallic solid supports modified with nucleic acids
US7045285B1 (en) 1996-11-05 2006-05-16 Clinical Micro Sensors, Inc. Electronic transfer moieties attached to peptide nucleic acids
US7160678B1 (en) 1996-11-05 2007-01-09 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
US6479240B1 (en) 1996-11-05 2002-11-12 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US7393645B2 (en) 1996-11-05 2008-07-01 Clinical Micro Sensors, Inc. Compositions for the electronic detection of analytes utilizing monolayers
US6458584B1 (en) 1996-12-23 2002-10-01 University Of Chicago Customized oligonucleotide microchips that convert multiple genetic information to simple patterns, are portable and reusable
US7267939B2 (en) 1997-06-12 2007-09-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US7514228B2 (en) 1997-06-12 2009-04-07 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US6686150B1 (en) 1998-01-27 2004-02-03 Clinical Micro Sensors, Inc. Amplification of nucleic acids with electronic detection
US6761816B1 (en) 1998-06-23 2004-07-13 Clinical Micro Systems, Inc. Printed circuit boards with monolayers and capture ligands
US7655129B2 (en) 1998-06-23 2010-02-02 Osmetech Technology Inc. Binding acceleration techniques for the detection of analytes
US9874542B2 (en) 1998-09-17 2018-01-23 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
US8501921B2 (en) 1998-10-27 2013-08-06 Osmetech Technology, Inc. Detection of target analytes using particles and electrodes
US6541617B1 (en) 1998-10-27 2003-04-01 Clinical Micro Sensors, Inc. Detection of target analytes using particles and electrodes
US6391937B1 (en) 1998-11-25 2002-05-21 Motorola, Inc. Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers
WO2000052208A3 (en) * 1999-03-03 2002-03-21 Univ Chicago Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
WO2000052208A2 (en) * 1999-03-03 2000-09-08 The University Of Chicago Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
US8486247B2 (en) 1999-04-21 2013-07-16 Osmetch Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US9151746B2 (en) 1999-04-21 2015-10-06 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US9557295B2 (en) 1999-04-21 2017-01-31 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US7449328B2 (en) 1999-05-03 2008-11-11 Gen-Probe Incorporated Probe matrix-based device for identifying microorganisms
EP1925678A1 (en) * 1999-05-03 2008-05-28 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
JP2002542808A (en) * 1999-05-03 2002-12-17 ジェン−プローブ・インコーポレーテッド Microbial identification method based on polynucleotide matrix
AU2005200846B2 (en) * 1999-05-03 2007-08-16 Gen-Probe Incorporated Probe matrix-based device for identifying microorganisms
WO2000066789A3 (en) * 1999-05-03 2001-05-03 Gen Probe Inc Polynucleotide matrix-based method of identifying microorganisms
WO2000066789A2 (en) * 1999-05-03 2000-11-09 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
AU778230B2 (en) * 1999-05-03 2004-11-25 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
US7935481B1 (en) 1999-07-26 2011-05-03 Osmetech Technology Inc. Sequence determination of nucleic acids using electronic detection
US6342359B1 (en) * 1999-10-01 2002-01-29 Lg Electronics Inc. Method for detecting nucleic acids, detector for nucleic acids and method for producing the same
WO2001036683A3 (en) * 1999-11-16 2002-09-26 Apollo Biotechnology Inc Method for rapid and accurate identification of microorganisms
WO2001036683A2 (en) * 1999-11-16 2001-05-25 Apollo Biotechnology, Inc. Method for rapid and accurate identification of microorganisms
EP1242631A1 (en) * 1999-12-15 2002-09-25 Conagra Grocery Products Companies Multispecies food testing and characterization
EP1242631A4 (en) * 1999-12-15 2003-07-16 Conagra Grocery Prod Co Multispecies food testing and characterization
US6878517B1 (en) 1999-12-15 2005-04-12 Congra Grocery Products Company Multispecies food testing and characterization organoleptic properties
EP1132485A3 (en) * 2000-03-10 2003-10-08 Hitachi Software Engineering Co., Ltd. Method and device for detecting hybridization reaction
EP1132485A2 (en) * 2000-03-10 2001-09-12 Hitachi Software Engineering Co., Ltd. Method and device for detecting hybridization reaction
US7202026B2 (en) 2000-03-24 2007-04-10 Eppendorf Array Technologies Sa (Eat) Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array
WO2001077372A3 (en) * 2000-03-24 2002-06-13 Univ Notre Dame De La Paix Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US7205104B2 (en) 2000-03-24 2007-04-17 Eppendorf Array Technologies Sa (Eat) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US7875442B2 (en) 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7829313B2 (en) 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
WO2001077372A2 (en) * 2000-03-24 2001-10-18 Facultes Universitaires Notre-Dame De La Paix Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
EP1136566A1 (en) * 2000-03-24 2001-09-26 Facultés Universitaires Notre-Dame de la Paix Method and kit for detection and/or quantification of homologus nucleotide sequences on arrays
WO2002029096A3 (en) * 2000-10-05 2003-05-15 Skuld Tech S A R L Fast method for detecting organisms in a sample
FR2815043A1 (en) * 2000-10-05 2002-04-12 Skuld Tech RAPID METHOD OF DETECTION OF ORGANISMS IN A SAMPLE
WO2002040711A1 (en) * 2000-11-17 2002-05-23 Biomerieux S.A. Method for analysing a patient's predisposition to insulin-dependent diabetes, device and set of primers
FR2816958A1 (en) * 2000-11-17 2002-05-24 Biomerieux Sa Assessing genetic predisposition to autoimmune diseases, specifically type I diabetes, by detecting polymorphisms associated with susceptibility, resistance or neutrality
US6960298B2 (en) 2001-12-10 2005-11-01 Nanogen, Inc. Mesoporous permeation layers for use on active electronic matrix devices
FR2833969A1 (en) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Biochip that carries high purity molecular probes, useful e.g. for diagnosis, specifically of breast cancer, and for analysis of DNA repair
FR2833968A1 (en) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Thematic biochip, useful e.g. for diagnosis, particularly of breast cancer, and treatment selection, comprises thematic probes and probes for interpretation
EP1469067A4 (en) * 2002-01-25 2007-05-23 Olympus Corp Method and apparatus for detecting nucleic acid data
EP1469067A1 (en) * 2002-01-25 2004-10-20 Olympus Corporation Method and apparatus for detecting nucleic acid data
EP1524320A1 (en) * 2003-10-15 2005-04-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Rapid determination and quantification of mycoplasma contamination using DNA chip technology
WO2005040420A1 (en) * 2003-10-15 2005-05-06 Dkfz Deutsches Krebsforschungszentrum Stiftung Des Öfffentlichen Rechts Rapid determination and quantification of mycoplasma contamination using dna chip technology
US7483188B2 (en) 2003-11-07 2009-01-27 De La Rue International Limited Security device
WO2005047012A1 (en) 2003-11-07 2005-05-26 De La Rue International Limited Security device
US7338763B2 (en) 2004-06-02 2008-03-04 Eppendorf Array Technologies S.A. Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
EP1812594B1 (en) * 2004-11-18 2013-01-09 Eppendorf Array Technologies Real-time quantification of multiple targets on a micro-array
EP1762628A1 (en) 2005-09-13 2007-03-14 Eppendorf Array Technologies SA Detection method of homologous sequences differing by one base on a microarray
EP1981985A1 (en) * 2006-01-05 2008-10-22 Simons Haplomics Limited Microarray methods
EP1981985A4 (en) * 2006-01-05 2009-11-11 Simons Haplomics Ltd Microarray methods
EP2277032A4 (en) * 2008-05-09 2011-10-26 Zhiping Liu A molecule detecting system
EP2277032A1 (en) * 2008-05-09 2011-01-26 Zhiping Liu A molecule detecting system
WO2017100454A1 (en) 2015-12-09 2017-06-15 Intuitive Biosciences, Inc. Automated silver enhancement system
EP3978619A1 (en) 2015-12-09 2022-04-06 Intuitive Biosciences, Inc. Automated silver enhancement system

Also Published As

Publication number Publication date
AU5716098A (en) 1998-07-17
WO1998028444A3 (en) 1998-12-17
EP0951569A2 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
US6458584B1 (en) Customized oligonucleotide microchips that convert multiple genetic information to simple patterns, are portable and reusable
EP0951569A2 (en) Customized oligonucleotide microchips as multiple biosensors
US6156502A (en) Arbitrary sequence oligonucleotide fingerprinting
EP0907752B1 (en) Method for determination of nucleic acid sequences and diagnostic applications thereof
US4683202A (en) Process for amplifying nucleic acid sequences
EP2182077B1 (en) A method for single nucleotide polymorphism and mutation detection using real time polymerase chain reaction microarray
US20160215327A1 (en) Optimization Of Gene Expression Analysis Using Immobilized Capture Probes
Dufva Introduction to microarray technology
US20020106646A1 (en) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
WO2005085476A1 (en) Detection of strp, such as fragile x syndrome
US20060177843A1 (en) Bioarray chip reaction apparatus and its manufacture
WO2005111237A1 (en) Detection of chromosomal disorders
IL153848A (en) Method of simultaneously genotyping multiple samples in a single round of hybridization
CA2374406A1 (en) Microarray-based analysis of polynucleotide sequence variations
EP2674492B1 (en) Method for detecting nucleic acid
EP1169474A1 (en) Olignucleotide array and methods of use
JP2002525127A (en) Methods and products for genotyping and DNA analysis
Li et al. DNA microarray technology in microbial ecology studies-principle, applications and current limitations
JP2000228999A (en) Multi-genotype of population
Wang et al. A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings
US7132236B2 (en) Composition and method for optimized hybridization using modified solutions
KR20060131972A (en) Dna array and method of detecting single nucleotide polymorphism
Jiang et al. A new method of preparing fiber-optic DNA biosensor and its array for gene detection
Sinibaldi et al. Gene expression analysis on medium-density oligonucleotide arrays
WO2003048727A2 (en) Identification of rearrangements in nucleic acid molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

WWE Wipo information: entry into national phase

Ref document number: 1997953408

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997953408

Country of ref document: EP